Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE003728 |
ID: | TCMBANKHE003728 |
植物拉丁名: |
|
功能与主治: | To reinforce the function of the spleen and replenish qi, to remove heat and counteract toxicity, to dispel phlegm and relieve cough, to alleviate spasmodic pain, and to moderate drug actions./1. Its decoction can inhibit intestinal smooth muscles of rabbins in vitro, but glycyrrhizin and glycyrrhetinic acid have no this effect.2. Possessing an adrenocorticomimetic effect.3. Its extract and glycyrrhizin exerts a detoxifying effect.4. Antitussive and antiasthmatic. 5. Glycyrrhizin has anti-inflammatory effect similar to hydrocortisone. |
药用植物名: | 甘草 |
药用部位: | root and rhizome |
药味: | Mild; Sweet |
经络: | Lung; Spleen; Stomach; Heart |
临床特征: | 1. Its decoction can inhibit intestinal smooth muscles of rabbins in vitro, but glycyrrhizin and glycyrrhetinic acid have no this effect.2. Possessing an adrenocorticomimetic effect.3. Its extract and glycyrrhizin exerts a detoxifying effect.4. Antitussiv |
治疗类型: | 补气药 |
TCM_ID_id: | 6801 |
SymMap_id: | 133 |
TCMSP_id: | 258 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000117 | kanzonols K | 436.54 | |||
| TCMBANKIN000137 | 1-Methoxyphaseollidin | AIDS-096030; AIDS096030; (6aR,11aR)-1-methoxy-10-(3-methylbut-2-enyl)-6a,11a-dihydro-6H-[1]benzoxolo[3,2-c]chromene-3,9-diol; (6aR,11aR)-1-Methoxy-10-(3-methyl-but-2-enyl)-6a,11a-dihydro-6H-benzofuro[3,2-c][1]benzopyran-3,9-diol; (6aR,11aR)-1-methoxy-10-(3-methylbut-2-enyl)-6a,11a-dihydro-6H-benzofurano[3,2-c]chromene-3,9-diol | C21H22O5 | 354.4 g/mol | CC(=CCC1=C(C=CC2=C1OC3C2COC4=C3C(=CC(=C4)O)OC)O)C |
| TCMBANKIN000306 | Gancaonin S | 4-{2-[2,4-Bis((2E)-3-methylbut-2-enyl)-3,5-dihydroxyphenyl]ethyl}benzene-1,2-diol; AIDS-095963; 4-(2-(2,4-Bis((2E)-3-methylbut-2-enyl)-3,5-dihydroxyphenyl)ethyl)benzene-1,2-diol; 5-[2-(3,4-dihydroxyphenyl)ethyl]-2,4-bis(3-methylbut-2-enyl)resorcinol; 5-[2-(3,4-dihydroxyphenyl)ethyl]-2,4-bis(3-methylbut-2-enyl)benzene-1,3-diol; 134958-54-6; gancaonin s; AIDS095963 | C24H30O4 | 382.49 | CC(=CCC1=C(C(=C(C=C1CCC2=CC(=C(C=C2)O)O)O)CC=C(C)C)O)C |
| TCMBANKIN000415 | glycyrrhisoflavone | AC1NSW0I; SCHEMBL12866237; 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxychromen-4-one; 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-chromen-4-one; ZINC14762993; 116709-70-7; Glycyrrhisoflavone; CHEMBL491515; NP-015153; BDBM50325940; MolPort-006-668-604; AKOS032962719 | C20H18O6 | 354.4 g/mol | CC(=CCC1=C(C(=CC(=C1)C2=COC3=CC(=CC(=C3C2=O)O)O)O)O)C |
| TCMBANKIN000898 | Uralene | 5,6,3',4'-Tetrahydroxy-3-methoxy-6'-isoprenylflavone; 2-[4,5-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-3-methoxy-4-chromenone; 2-(4,5-Dihydroxy-2-(3-methylbut-2-en-1-yl)phenyl)-5,6-dihydroxy-3-methoxy-4H-chromen-4-one; SCHEMBL3977970; LMPK12111615; 4',5,5',6-tetrahydroxy-3-methoxy-2'-prenylflavone; AC1Q6E0V; AKOS030553602; uralene; 4H-1-Benzopyran-4-one, 2-(4,5-dihydroxy-2-(3-methyl-2-butenyl)phenyl)-5,6-dihydroxy-3-methoxy-; 2-[4,5-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-3-methoxy-chromen-4-one; AC1L4UEU; 2-[4,5-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-3-methoxy-chromone; 150853-99-9; 2-[4,5-Dihydroxy-2-(3-methyl-2-butenyl)phenyl]-5,6-dihydroxy-3-methoxy-4H-1-benzopyran-4-one; AK583653; 2-[4,5-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-5,6-dihydroxy-3-methoxychromen-4-one | C21H20O7 | 384.38 | CC(=CCC1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=CC(=C3O)O)OC)O)O)C |
| TCMBANKIN000901 | tetrahydroharmine | (R)-Tetrahydroharmine; (+)-Tetrahydroharmine; UNII-F1Q1E0G45A component ZXLDQJLIBNPEFJ-MRVPVSSYSA-N; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (1R)-; 7759-46-8; ZINC2112084; AC1L9CA2; (1r)-tetrahydroharmine; AF812R7053; UNII-AF812R7053; CHEBI:9485; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (R)-; (1R)-7-methoxy-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole; C09243; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (+)- | C13H16N2O | 216.28 g/mol | CC1C2=C(CCN1)C3=C(N2)C=C(C=C3)OC |
| TCMBANKIN001237 | Kanzonol H | 152511-46-1; 4-[(3R)-5-methoxy-8,8-dimethyl-3,4,6,7-tetrahydro-2H-pyrano[5,6-g]chromen-3-yl]-2-(3-methylbut-2-enyl)benzene-1,3-diol; AIDS096019; AIDS-096019; 4-((R)-5-Methoxy-8,8-dimethyl-3,4,7,8-tetrahydro-2H,6H-benzo(1,2-b:5,4-b')dipyran-3-yl)-2-(3-methyl-but-2-enyl)-benzene-1,3-diol; 4-[(3R)-5-methoxy-8,8-dimethyl-3,4,6,7-tetrahydro-2H-pyrano[5,6-g]chromen-3-yl]-2-(3-methylbut-2-enyl)resorcinol; 4-((R)-5-Methoxy-8,8-dimethyl-3,4,7,8-tetrahydro-2H,6H-benzo[1,2-b:5,4-b']dipyran-3-yl)-2-(3-methyl-but-2-enyl)-benzene-1,3-diol; kanzonol h | C26H32O5 | 424.53 | CC(=CCC1=C(C=CC(=C1O)C2CC3=C(C=C4C(=C3OC)CCC(O4)(C)C)OC2)O)C |
| TCMBANKIN001493 | 8-methyl-10-hydroxylycoctonine | CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4(C5C6OC)O)OC)OC)O)OC)OC)CO | |||
| TCMBANKIN001552 | licorice-saponin K2_qt | 470.76 | |||
| TCMBANKIN001589 | gadelaidic acid | 506-31-0; (9E)-icos-9-enoic acid; CHEBI:32422; trans-Delta(9)-eicosenoic acid; EINECS 208-032-9; Icos-9-enoic acid; (E)-icos-9-enoic acid; LMFA01030700; 9-Eicosenoic acid; (E)-eicos-9-enoic acid | C20H38O2 | 310.51 | CCCCCCCCCCC=CCCCCCCCC(=O)O |
| TCMBANKIN001649 | Licorice glycoside A | licorice glycoside a | C36H38O16 | 726.7 g/mol | COC1=C(C=CC(=C1)C=CC(=O)OCC2(COC(C2O)OC3C(C(C(OC3OC4=CC=C(C=C4)C=CC(=O)C5=C(C=C(C=C5)O)O)CO)O)O)O)O |
| TCMBANKIN002258 | Glepidotin A | 8-(3,3-Dimethylallyl)galangin; 3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenylchromen-4-one; 3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-chromen-4-one; 8-(3,3-DMA)galangin; 3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-chromone; glepidotin a; 42193-83-9; 3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-4-chromenone; 8-Prenylgalangin; C10049 | C20H18O5 | 338.35 | CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC=CC=C3)O)C |
| TCMBANKIN002389 | 3-o-acetyl-glycyrrhetinicacid | C32H48O5 | |||
| TCMBANKIN002487 | 18α-hydroxyglycyrrhetic acid | 18α-hydroxy glycyrrheticacid | C30H46O5 | 486.68 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4(CC(CC5)(C)C(=O)O)O)C)C)C)C |
| TCMBANKIN002638 | 3β-formylglabrolide | 496.75 | |||
| TCMBANKIN002668 | 3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(3-methylbut-2-enyl)chromone | 3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(3-methylbut-2-enyl)chromen-4-one; 3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(3-methylbut-2-enyl)-4-chromenone | C20H18O6 | 354.35 | |
| TCMBANKIN003660 | 1,3-dihydroxy-9-methoxy-6-benzofurano[3,2-c]chromenone | 1,3-dihydroxy-9-methoxy-benzofurano[3,2-c]chromen-6-one; 1,3-dihydroxy-9-methoxy-[1]benzoxolo[3,2-c]chromen-6-one | 298.26 | ||
| TCMBANKIN003710 | 3,3-Dimethylpentane | 562-49-2; InChI=1/C7H16/c1-5-7(3,4)6-2/h5-6H2,1-4H; 118451_ALDRICH; NSC74150; EINECS 209-230-8; FR-2188; 3,3-dimethyl pentane; NSC 74150; Pentane, 3,3-dimethyl- | C7H16 | 100.2 | CCC(C)(C)CC |
| TCMBANKIN003718 | soy lecithin | ||||
| TCMBANKIN004306 | apioglycyrrhizin_qt | C41H62O14 | 778.92 | ||
| TCMBANKIN004763 | 2-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]-5-methoxyphenol | 2-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]-5-methoxy-phenol | 338.43 | ||
| TCMBANKIN004803 | licorice-saponin F3_qt | 454.76 | |||
| TCMBANKIN004879 | glyinflanin A | C25H28O5 | 408.5 g/mol | CC(=CCC1=CC(=C(C=C1O)O)C(=O)C=C(C2=CC(=C(C=C2)O)CC=C(C)C)O)C | |
| TCMBANKIN005187 | 2,3-dimethylhexane | 2,3-dimethyl-hexane | C8H18 | 114.23 | CCCC(C)C(C)C |
| TCMBANKIN005653 | Glypallichalcone | (E)-3-(4-hydroxy-2-methoxy-phenyl)-1-(4-methoxyphenyl)prop-2-en-1-one; 2-Propen-1-one, 3-(4-hydroxy-2-methoxyphenyl)-1-(4-methoxyphenyl)-, (E)-; (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one; 4-Hydroxy-2,4'-dimethoxychalcone; AC1NSW0O; glypallichalcone; 4-Hydroxy-2,4/'-dimethoxychalcone; LMPK12120432; 146763-58-8 | C17H16O4 | 284.31 | COC1=CC=C(C=C1)C(=O)C=CC2=C(C=C(C=C2)O)OC |
| TCMBANKIN005878 | 3-o-[β-d-glucuronopyranosyl-(1→2)-o-β-d-glucuronopyranosyl]-24-hydroxyglabrolide | C43H62O17257 | |||
| TCMBANKIN006096 | methylglycyrrhetate | C31H48O4 | 484.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)OC)C)C)C)C | |
| TCMBANKIN006375 | 7-Acetoxy-2-methylisoflavone | STOCK1N-08402; Oprea1_280944; acetic acid (2-methyl-4-oxo-3-phenyl-7-chromenyl) ester; acetic acid (4-keto-2-methyl-3-phenyl-chromen-7-yl) ester; 3211-63-0; 7-acetoxy-2-methylisoflavone; SMR000387028; ZINC00189892; Oprea1_018493; MLS001049043; NSC108339; (2-methyl-4-oxo-3-phenylchromen-7-yl) acetate; (2-methyl-4-oxo-3-phenyl-chromen-7-yl) ethanoate; (2-methyl-4-oxo-3-phenyl-chromen-7-yl) acetate | C18H14O4 | 294.3 | CC1=C(C(=O)C2=C(O1)C=C(C=C2)OC(=O)C)C3=CC=CC=C3 |
| TCMBANKIN006434 | narcissin | LMPK12110586; Narcissin; SCHEMBL1305421 | C28H32O16 | 624.54 | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)O)O)O)O)O)O |
| TCMBANKIN006711 | sinapic acid | A829376; (E)-3-(4-hydroxy-3,5-dimethoxy-phenyl)prop-2-enoic acid; 3-(3,5-Dimethoxy-4-hydroxyphenyl)acrylate; ST5308240; (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid; InChI=1/C11H12O5/c1-15-8-5-7(3-4-10(12)13)6-9(16-2)11(8)14/h3-6,14H,1-2H3,(H,12,13; 85429_FLUKA; 2-propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (2E)-; 3,5-Dimethoxy-4-hydroxycinnamic acid; (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate; (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid; ZB005508; 2-propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-; C00482; sinapicacid; 49508_FLUKA; MLS001066354; Sinapic acid; SXX; 3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid; 3,5-dimethoxy-4-hydroxycinnamic acid; 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid; trans-sinapate; AIDS024970; (E)-3-(3,5-dimethoxy-4-oxidanyl-phenyl)prop-2-enoate; AC1NUT1R; NSC59261; (E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid; CHEBI:30023; 4-Hydroxy-3,5-dimethoxy-cinnamic acid; 2-Propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)-; Synapoic acid; SINAPINATE; (E)-3-(4-hydroxy-3,5-dimethoxy-phenyl)acrylic acid; 530-59-6; AIDS-024970; D7927_SIGMA; SMR000471879; (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenoate; (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid; CHEBI:15714; CINNAMIC ACID,3,5-DIMETHOXY,4-HYDROXY; (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate; Cinnamic acid, 4-hydroxy-3,5-dimethoxy-, (E)-; (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid; InChI=1/C11H12O5/c1-15-8-5-7(3-4-10(12)13)6-9(16-2)11(8)14/h3-6,14H,1-2H3,(H,12,13)/b4-3; 7362-37-0; 3-(4-hydroxy-3,5-dimethoxy-phenyl)acrylic acid; 3-(4-hydroxy-3,5-dimethoxy-phenyl)prop-2-enoic acid; 3,5-dimethoxy-4-hydroxycinnamate; 4-hydroxy-3,5-dimethoxycinnamate | C11H12O5 | 224.21 | COC1=CC(=CC(=C1O)OC)C=CC(=O)O |
| TCMBANKIN006845 | berniarin | ||||
| TCMBANKIN006955 | liquiritigenin-7-o-β-d-(3-o-acetyl)-apio-furanosyl-4'-o-β-d-glucopyranoside | liquiritigenin-7-o-beta-d-(3-o-acetyl)-apiofuranosyl-4'-o-beta-d-glucopyranoside | |||
| TCMBANKIN007092 | glucuronic acid | ZINC3869801; CHEBI:28860; glucuronicacid; C08350; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxytetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxy-2-tetrahydropyrancarboxylic acid; BDP; beta-D-Glucuronic acid; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid; GCU; BETA-D-GALACTOPYRANURONIC ACID; beta-L-Altropyranuronic acid; beta-D-Glucopyranuronic acid; SCHEMBL15596882; BIG1006 | C6H10O7 | 194.14 | C1(C(C(OC(C1O)O)C(=O)O)O)O |
| TCMBANKIN007167 | uralenneoside | AC1L3197; Uralenneoside; 1-O-Protocatechuyl-beta-xylose; [(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl] 3,4-dihydroxybenzoate; beta-D-Xylopyranose, 1-(3,4-dihydroxybenzoate); (2S,3R,4S,5R)-3,4,5-TRIHYDROXYOXAN-2-YL 3,4-DIHYDROXYBENZOATE; 143986-30-5; 3,4-dihydroxybenzoyl beta-d-xylopyranoside | C12H14O8 | 286.23 | C1C(C(C(C(O1)OC(=O)C2=CC(=C(C=C2)O)O)O)O)O |
| TCMBANKIN007226 | licorice-saponin H2_qt | 470.76 | |||
| TCMBANKIN007387 | Kanzonol F | kanzonol f | C26H28O5 | 420.5 g/mol | CC(=CCC1=C(C2=C(C=C1O)OCC3C2OC4=C3C=C5C=CC(OC5=C4)(C)C)OC)C |
| TCMBANKIN007455 | Uralenol | CHEMBL113833; SCHEMBL1170912; 3,5,7,3',4'-Pentahydroxy-5'-isoprenylflavone; 2-[3,4-Dihydroxy-5-(3-methyl-but-2-enyl)-phenyl]-3,5,7-trihydroxy-chromen-4-one; DTXSID50160946; BDBM50121024; 2-[3,4-Dihydroxy-5-(3-methyl-2-butenyl)phenyl]-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-3,5,7-trihydroxy-4-chromenone; 3',4',5,7-Tetrahydroxy-5'-prenylflavonol; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-3,5,7-trihydroxy-chromen-4-one; LMPK12112286; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-3,5,7-trihydroxy-chromone; 139163-15-8; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl)-3,5,7-trihydroxy-; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-3,5,7-trihydroxychromen-4-one; uralenol; AC1NSSOO | C20H18O7 | 370.35 | CC(=CCC1=C(C(=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O)C |
| TCMBANKIN007479 | Neouralenol | 2-[3,4-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-3,6,7-trihydroxy-chromen-4-one; 2-[3,4-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-3,6,7-trihydroxy-4-chromenone; 3,6,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enoxy)phenyl]chromen-4-one; XHGNOEWBXVPYDM-UHFFFAOYSA-N; 4H-Benzopyran-4-one, 2-(3,4-dihydroxy-2-(3-methyl-2-butenyl)phenyl)-3,6,7-trihydroxy-; 139163-16-9; neouralenol; AC1NUP13; 2-[3,4-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-3,6,7-trihydroxychromen-4-one; 2-[3,4-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-3,6,7-trihydroxy-chromone; DTXSID10160947 | C20H18O7 | 370.4 g/mol | CC(=CCC1=C(C=CC(=C1O)O)C2=C(C(=O)C3=CC(=C(C=C3O2)O)O)O)C |
| TCMBANKIN008147 | 1,3-dihydroxy-8,9-dimethoxy-6-benzofurano[3,2-c]chromenone | 1,3-dihydroxy-8,9-dimethoxy-[1]benzoxolo[3,2-c]chromen-6-one; 1,3-dihydroxy-8,9-dimethoxy-benzofurano[3,2-c]chromen-6-one | 328.29 | ||
| TCMBANKIN008481 | Ruvoside | 3-[(5R,10R,14S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10-(hydroxymethyl)-13-methyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; ruvoside; AC1O3DXD | C30H46O9 | 550.68 | [HH].CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)CO)O)OC)O |
| TCMBANKIN009371 | uralenin | AC1NSSOL; DTXSID70160948; Uralenin; 5,7,3',4'-Tetrahydroxy-5'-isoprenylflavanone; 139163-17-0; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl)-5,7-dihydroxy-; 2-[3,4-DIHYDROXY-5-(3-METHYLBUT-2-EN-1-YL)PHENYL]-5,7-DIHYDROXYCHROMEN-4-ONE; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxychromen-4-one | C20H18O6 | 354.4 g/mol | CC(=CCC1=C(C(=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O)C |
| TCMBANKIN009413 | 22β-acetylglabric acid | 528.8 | |||
| TCMBANKIN009589 | licorice-saponin G2_qt | 486.76 | |||
| TCMBANKIN009657 | Gancaonin C | 5,7-dihydroxy-8-[(E)-4-hydroxy-3-methylbut-2-enyl]-3-(4-hydroxyphenyl)-4-chromenone; AIDS-096028; 4',5,7-Trihydroxy-8-(4-hydroxyprenyl)isoflavone; 5,7-dihydroxy-8-[(E)-4-hydroxy-3-methyl-but-2-enyl]-3-(4-hydroxyphenyl)chromone; 5,7-Dihydroxy-8-(4-hydroxy-3-methyl-2-butenyl)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; LMPK12050197; 124596-87-8; AK583696; gancaonin c; AKOS030553637; 5,7-dihydroxy-8-[(E)-4-hydroxy-3-methylbut-2-enyl]-3-(4-hydroxyphenyl)chromen-4-one; AC1O52LR; (E)-5,7-Dihydroxy-8-(4-hydroxy-3-methylbut-2-en-1-yl)-3-(4-hydroxyphenyl)-4H-chromen-4-one; AIDS096028; 5,7,4'-Trihydroxy-8-(4-hydroxyprenyl)isoflavone; 5,7-dihydroxy-8-[(E)-4-hydroxy-3-methyl-but-2-enyl]-3-(4-hydroxyphenyl)chromen-4-one; 5,7-Dihydroxy-8-((E)-4-hydroxy-3-methyl-but-2-enyl)-3-(4-hydroxy-phenyl)-1-benzopyran-4-one | C20H18O6 | 354.35 | CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=CO2)C3=CC=C(C=C3)O)CO |
| TCMBANKIN009693 | Phaseolinisoflavan | 40323-57-7; 6-[(3R)-7-hydroxychroman-3-yl]-2,2-dimethyl-chromen-5-ol; phaseolinisoflavan; (-)-Phaseollinisoflavan; (3,6'-Bi-2H-1-benzopyran)-5',7-diol, 3,4-dihydro-2',2'-dimethyl-, (R)-; C10515; 6-[(3R)-7-hydroxychroman-3-yl]-2,2-dimethylchromen-5-ol; 6-[(3R)-7-hydroxy-3-chromanyl]-2,2-dimethyl-5-chromenol | C20H20O4 | 324.37 | CC1(C=CC2=C(O1)C=CC(=C2O)C3CC4=C(C=C(C=C4)O)OC3)C |
| TCMBANKIN010198 | Licoricone | LMPK12050069; 7-hydroxy-3-[6-hydroxy-2,4-dimethoxy-3-(3-methylbut-2-enyl)phenyl]chromone; 7-hydroxy-3-[6-hydroxy-2,4-dimethoxy-3-(3-methylbut-2-enyl)phenyl]chromen-4-one; 51847-92-8; AKOS032949107; 7-hydroxy-3-[6-hydroxy-2,4-dimethoxy-3-(3-methylbut-2-en-1-yl)phenyl]-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(6-hydroxy-2,4-dimethoxy-3-(3-methyl-2-butenyl)phenyl)-; CHEBI:69094; 2',7-Dihydroxy-4',6'-dimethoxy-3'-prenylisoflavone; AIDS095918; CTK1H2337; AIDS-095918; T8X3270QWW; UNII-T8X3270QWW; AC1NSXJZ; licoricone; 7-hydroxy-3-[6-hydroxy-2,4-dimethoxy-3-(3-methylbut-2-enyl)phenyl]-4-chromenone; ZINC14762987; C17765; 7-Hydroxy-3-[6-hydroxy-2,4-dimethoxy-3-(3-methyl-but-2-enyl)-phenyl]-1-benzopyran-4-one | C22H22O6 | 382.41 | CC(=CCC1=C(C=C(C(=C1OC)C2=COC3=C(C2=O)C=CC(=C3)O)O)OC)C |
| TCMBANKIN010339 | Isoononin | 7-methoxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one; 7-methoxy-3-[4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]-4-chromenone; 155421-51-5; isoononin; AC1NSX3C; 7-methoxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]chromen-4-one; 7-methoxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxyphenyl]chromone | C22H22O9 | 430.4 g/mol | COC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O |
| TCMBANKIN010372 | Licoricidin | AIDS096021; AIDS-096021; 5,2',4'-Trihydroxy-7-methoxy-6,3'-diprenylisoflavan; 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chroman-3-yl]-2-(3-methylbut-2-enyl)resorcinol; LMPK12080045; 30508-27-1; licoricidin ; 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)-3-chromanyl]-2-(3-methylbut-2-enyl)benzene-1,3-diol; SCHEMBL744306; 4-[(R)-7-Hydroxy-5-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl]-2-((E)-3-methyl-but-2-enyl)-benzene-1,3-diol; 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chroman-3-yl]-2-(3-methylbut-2-enyl)benzene-1,3-diol; 4-((R)-7-Hydroxy-5-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl)-2-((E)-3-methyl-but-2-enyl)-benzene-1,3-diol; licoricidin | C26H32O5 | 424.53 | CC(=CCC1=C(C=CC(=C1O)C2CC3=C(C=C(C(=C3OC)CC=C(C)C)O)OC2)O)C |
| TCMBANKIN010538 | (2S)-7-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one | 31524-62-6; (2S)-7-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-4-chromanone | C20H20O4 | 324.37 | CC(=CCC1=C(C=CC2=C1OC(CC2=O)C3=CC=C(C=C3)O)O)C |
| TCMBANKIN010785 | licorice-saponin C2_qt | 3β-hydroxyolean-11,13(18)-dien-30-oic acid | C30H46O3 | 454.68 | |
| TCMBANKIN010856 | uralsaponin a | C42H62O16 | 822.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN011180 | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methylbut-2-enyl)chromone | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methylbut-2-enyl)-4-chromenone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methylbut-2-enyl)chromen-4-one | C20H18O6 | 354.35 | |
| TCMBANKIN011240 | kanzonols T | 440.53 | |||
| TCMBANKIN011376 | neoisopulegol | C10H18O | 154.25 g/mol | CC1CCC(C(C1)O)C(=C)C | |
| TCMBANKIN011519 | (1S,2S)-1,2-dimethylcyclopentane | cyclopentane, 1,2-dimethyl-, (1S,2S)-; InChI=1/C7H14/c1-6-4-3-5-7(6)2/h6-7H,3-5H2,1-2H3/t6-,7-/m0/s | C7H14 | 98.19 | CC1CCCC1C |
| TCMBANKIN011771 | (2R)-7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chroman-4-one | (2R)-7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-4-chromanone; ZINC04716495 | 324.4 | ||
| TCMBANKIN012416 | 2-Tetradecanone | Tetradecan-2-one; 2345-27-9; EINECS 219-063-2 | C14H28O | 212.37 | CCCCCCCCCCCCC(=O)C |
| TCMBANKIN012762 | 3-Methylpentane | 96-14-0; NSC 66497; 68320_FLUKA; NSC66497; InChI=1/C6H14/c1-4-6(3)5-2/h6H,4-5H2,1-3H; M66005_ALDRICH; 442390_SUPELCO; Pentane, 3-methyl-; 3-methylpentane; AI3-28852; EINECS 202-481-4; HSDB 5300; 68322_FLUKA; Diethylmethylmethane | C6H14 | 86.18 | CCC(C)CC |
| TCMBANKIN013366 | glyeurysaponin | C42H62O16 | 822.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN013454 | Licoagrocarpin | C21H22O4 | 338.4 g/mol | CC(=CCC1=C(C=CC2=C1OCC3C2OC4=C3C=CC(=C4)OC)O)C | |
| TCMBANKIN013745 | 7,2',4'-trihydroxy－5-methoxy-3－arylcoumarin | 300.28 | |||
| TCMBANKIN014213 | 21987_FLUKA | (1S,3R)-cis-4-Carene; (1R,4R)-4,7,7-Trimethylbicyclo[4.1.0]hept-2-ene; (1S,3R,6R)-3,7,7-trimethylbicyclo[4.1.0]hept-4-ene | C10H16 | 136.23 | CC1CC2C(C2(C)C)C=C1 |
| TCMBANKIN014592 | 2-methyl-6-ethyl decane | C13H28 | 184.36 | CCCCC(CC)CCCC(C)C | |
| TCMBANKIN014627 | Glycyrin | CTK2F4785; UNII-994BQ9M3AV; AC1Q69MO; DTXSID50216255; 3-(2,4-dihydroxyphenyl)-5,7-dimethoxy-6-(3-methylbut-2-enyl)-2-chromenone; 994BQ9M3AV; 3-(2,4-Dihydroxyphenyl)-5,7-dimethoxy-6-(3-methyl-2-butenyl)-2H-1-benzopyran-2-one, 9CI; SCHEMBL5327472; CHEMBL132535; AIDS-095928; 3-(2,4-Dihydroxy-phenyl)-5,7-dimethoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-2-one; 3-(2',4'-dihydroxyphenyl)-5,7-dimethoxy-2-isopentenylcoumarin; 4CN-3204; 3-(2,4-Dihydroxyphenyl)-5,7-dimethoxy-6-prenylcoumarin; CHEBI:69086; glycyrin; LMPK12160017; AC1LA3F7; MCULE-5289975867; 3-(2,4-dihydroxyphenyl)-5,7-dimethoxy-6-(3-methylbut-2-enyl)coumarin; AIDS095928; 66056-18-6; ZINC5854529; AKOS032949083; NP-016587; 3-(2,4-dihydroxyphenyl)-5,7-dimethoxy-6-(3-methylbut-2-enyl)chromen-2-one; 3-(2,4-dihydroxyphenyl)-5,7-dimethoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-2-one; 3-(2,4-dihydroxyphenyl)-5,7-dimethoxy-6-(3-methylbut-2-en-1-yl)-2h-chromen-2-one | C22H22O6 | 382.41 | CC(=CCC1=C(C=C2C(=C1OC)C=C(C(=O)O2)C3=C(C=C(C=C3)O)O)OC)C |
| TCMBANKIN015244 | (3S)-2,3-dimethylpentane | C7H16 | 100.2 | ||
| TCMBANKIN015416 | 2,7-dihydroxy-4-methoxyphenanthrene-2,7-O-diglucoside | 550.56 | |||
| TCMBANKIN015600 | 3-hydroxy-heptanoic acid | C7H14O3 | 146.18 g/mol | CCCCC(CC(=O)O)O | |
| TCMBANKIN015638 | phaseollinisoflavan | CHEMBL465812; UNII-3A9F71823M; Phaseollinisoflavan; AC1L4R8F; CHEBI:109; 3A9F71823M; LMPK12080014; 6-(7-hydroxychroman-3-yl)-2,2-dimethyl-2H-chromen-5-ol; DTXSID60193326; (3R)-2',2'-dimethyl-3,4-dihydro-2H,2'H-3,6'-bichromene-5',7-diol; (3R)-3,4-Dihydro-2',2'-dimethyl-3,6'-bi[2H-1-benzopyran]-5',7-diol; C10515; 40323-57-7; AC1Q7BE7; Phaseollin (isoflavan); (-)-Phaseollinisoflavan; 6-[(3R)-7-hydroxy-3,4-dihydro-2H-chromen-3-yl]-2,2-dimethylchromen-5-ol; (3,6'-Bi-2H-1-benzopyran)-5',7-diol, 3,4-dihydro-2',2'-dimethyl-, (R)-; (3,6'-bi-2h-1-benzopyran)-5',7-diol, 3,4-dihydro-2',2'-dimethyl-,(r)- | C20H20O4 | 324.4 g/mol | CC1(C=CC2=C(O1)C=CC(=C2O)C3CC4=C(C=C(C=C4)O)OC3)C |
| TCMBANKIN015721 | licorice-saponin J2_qt | 472.78 | |||
| TCMBANKIN015747 | 8-(6-hydroxy-2-benzofuranyl)-2,2-dimethyl-5-chromenol | 8-(6-hydroxy-1-benzofuran-2-yl)-2,2-dimethylchromen-5-ol; 8-(6-hydroxybenzofuran-2-yl)-2,2-dimethyl-chromen-5-ol; 8-(6-hydroxy-1-benzofuran-2-yl)-2,2-dimethyl-chromen-5-ol | 308.35 | ||
| TCMBANKIN015820 | 24-hydroxy-12β-acetoxy-25,26,27-trinorcyclo-artan-16,23-dione 3β-o-α-l-arabinopyranoside | C34H52O10 | CC(CC(=O)CO)C1C(=O)CC2(C1(C(CC34C2CCC5C3(C4)CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)OC(=O)C)C)C | ||
| TCMBANKIN015830 | 3-(2-hydroxy-4-methoxyphenyl)-2H-chromen-7-ol | 3-(2-hydroxy-4-methoxy-phenyl)-2H-chromen-7-ol | 270.3 | ||
| TCMBANKIN016300 | Sigmoidin-B | (2S)-2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-4-chromanone; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl)-2,3-dihydro-5,7-di- hydroxy-, (S)-; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl)-2,3-dihydro-5,7-dihydroxy-, (S)-; Sigmoidin B; 87746-47-2; AIDS-071729; (2S)-2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-chroman-4-one; (2S)-2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxychroman-4-one; AIDS071729 | C20H20O6 | 356.37 | CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O)O)C |
| TCMBANKIN016333 | Karenzu DK2 | SPECTRUM1505311; Spectrum3_001950; 1,3-Diphenylpropane-1,3-dione; AIDS017990; 1,3-Propanedione, 1,3-diphenyl-; Rhodiastab 83; 2-Benzoylacetophenone; AIDS-017990; AI3-19022; KBio3_002841; NCGC00095298-01; SPBio_000135; 1,3-di(phenyl)propane-1,3-dione; Phenyl phenacyl ketone; NCGC00095298-02; Dibenzoylmethane; .omega.-Benzoylacetophenone; BSPBio_003550; 120-46-7; Spectrum2_000038; NSC 6266; NSC6266; Dibenzoyl-methane; 61346-73-4; BRN 0514910; omega-Benzoylacetophenone; EINECS 204-398-9; D33454_ALDRICH; 1,3-Diphenyl-1,3-propanedione; ST5319429 | C15H12O2 | 224.25 | C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=CC=C2 |
| TCMBANKIN016628 | Glyasperins M | 368.41 | |||
| TCMBANKIN016632 | 8-methoxy-5-o-glucoside flavone | 8-methoxy-2-phenyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; AC1NSY3A | COC1=C2C(=C(C=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C=C(O2)C4=CC=CC=C4 | ||
| TCMBANKIN016653 | formononetin-7-glucoside | C22H22O9 | 430.4 g/mol | COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O | |
| TCMBANKIN016780 | Gancaonin V | AIDS-095964; AIDS095964; 134958-57-9; gancaonin v; 8-(3-Methyl-but-2-enyl)-9,10-dihydro-phenanthrene-2,3,5,7-tetraol; 8-(3-methylbut-2-enyl)-9,10-dihydrophenanthrene-2,3,5,7-tetrol | C19H20O4 | 312.36 | CC(=CCC1=C2CCC3=CC(=C(C=C3C2=C(C=C1O)O)O)O)C |
| TCMBANKIN016793 | Inermine | C10502; (-)-Maackiain; 6H-(1,3)Dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-3-ol, 6a,12a-dihydro-, (6aR-cis)-; ST077155; 2035-15-6 | C16H12O5 | 284.26 | C1C2C(C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)OCO5 |
| TCMBANKIN016843 | monoammonium glycyrrhizinate | AC-13552; BC206410; AKOS015961327 | C42H65NO16 | 840 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C.N |
| TCMBANKIN016878 | vicianin | Benzeneacetonitrile, alpha-((6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranosyl)oxy)-, (R)-; (2R)-2-phenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile; Vicianin; CQU61CXY3D; AC1O533C; UNII-CQU61CXY3D | C19H25NO10 | 427.4 g/mol | C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C#N)C3=CC=CC=C3)O)O)O)O)O)O |
| TCMBANKIN016912 | beta-Glycyrrhetinic acid | BRN 2956366; 3-beta-Hydroxy-11-oxo-18-alpha-olean-12-en-30-oic acid; (3beta,18alpha,20beta)-3-Hydroxy-11-oxoolean-12-en-29-oic acid; EINECS 215-907-9; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bS)-10-hydroxy-13-keto-2,4a,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; S00283; NSC 35350; 18-alpha-Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-; 18alpha-Glycyrrhetinic acid; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; 18alpha-Glycyrrhetinic acid; 3?-Hydroxy-11-oxo-18?,20?-olean-12-en-29-oic acid; CCRIS 3963 | C30H46O4 | 470.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN017115 | 4,2',4',alpha-Tetrahydroxydihydrochalcone | C15H14O5 | 274.27 g/mol | C1=CC(=CC=C1CC(C(=O)C2=C(C=C(C=C2)O)O)O)O | |
| TCMBANKIN017179 | Glyasperins K | 368.46 | |||
| TCMBANKIN017322 | licoricesaponine h2 | ||||
| TCMBANKIN017348 | Gancaonin Q | 134958-52-4; AIDS-095948; gancaonin q; 5,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromone; AIDS095948; 5,7-Dihydroxy-2-(4-hydroxy-3-((E)-3-methyl-but-2-enyl)-phenyl)-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one; 5,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromen-4-one; 5,7-Dihydroxy-2-[4-hydroxy-3-((E)-3-methyl-but-2-enyl)-phenyl]-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one; 5,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)-4-chromenone | C25H26O5 | 406.47 | CC(=CCC1=C(C=CC(=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)CC=C(C)C)O)O)C |
| TCMBANKIN018731 | Cyclobutanol, 1-ethyl- | 84256-19-9; 1-ethyl-1-cyclobutanol; 1-ethylcyclobutan-1-ol | C6H12O | 100.16 g/mol | CCC1(CCC1)O |
| TCMBANKIN018979 | (2R)-2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-enyl)chroman-4-one | (2R)-2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-enyl)-4-chromanone | C25H28O6 | 424.49 | |
| TCMBANKIN019163 | (Z)-1-(2,4-dihydroxyphenyl)-3-phenylprop-2-en-1-one | (Z)-1-(2,4-dihydroxyphenyl)-3-phenyl-prop-2-en-1-one | 240.27 | ||
| TCMBANKIN019471 | methylglyoxal | Propanal, 2-oxo-; FT-0646558; CH3COCHO; oxopropanal; Propionaldehyde, 2-keto; Pyruvaldehyde solution; Pyroracemic aldehyde; alpha-Ketopropionaldehyde; 78-98-8; D07QPX; NSC-133493; 51252-84-7; Methylglyoxal solution, technical, ~40% in H2O; H451; RP00358; Propanedione; I14-13930; NSC626580; F0001-2060; PVL; pyruvaldehyde; NSC-133492; 2-oxopropanoyl; 2-Ketopropionaldehyde; Methylglyoxal solution; 2-Oxopropanal; D0G4CI; Ketopropionaldehyde; Pyruvoyl Group; ANW-37250; METHYL GLYOXAL; pyruvic aldehyde; 2-oxo-Propionaldehyde; Propanolone; KSC377C2D; Pyruvaldehyde polymer; CAS-78-98-8; BRN 0906750; RTR-025193; CCRIS 1741; EINECS 201-164-8; AN-23972; Tox21_303931; Methylglyoxal solution 40% in water; LS-139762; 1-Ketopropionaldehyde; AC1Q1JBB; acetylformaldehyde; Pyruvaldehyde solution, 40 wt. % in H2O; Propanal, 2-oxo- (9CI); C00546; KS-0000006N; NSC-626580; EC 201-164-8; CHEMBL170721; FEMA No. 2969; Propionaldehyde, 2-oxo-; NSC133493; CTK2H7121; GTPL6303; AB00820; AKOS000119318; DB03587; 1,2-Propanedione; acetyl formaldehyde; Acetylformyl; BP-20618; NSC-79019; 4-01-00-03631 (Beilstein Handbook Reference); Pyruvaldehyde (8CI); SC-74380; alpha-Ketopropionic aldehyde; DSSTox_GSID_21628; WLN: VHV1; AC1Q1JBA; .alpha.-Ketopropionaldehyde; 2-oxo-propanal; Glyoxal, methyl; DTXSID0021628; NSC79019; LTBB001468; DSSTox_CID_1628; AIJULSRZWUXGPQ-UHFFFAOYSA-N; 722KLD7415; NSC 79019; J-510228; Pyruvic Aldehyde (40% solution); HSDB 7510; 129393-62-0; 2-keto Propionaldehyde; NSC 337790; KB-60264; MFCD00006960; NSC 626580; UNII-722KLD7415; METHYL GLYOXAL, 30% IN WATER; methyl-glyoxal; Acetalformaldehyde; 2-Oxopropionaldehyde; KM1949; ZINC1532681; NSC133492; NCGC00356972-01; MCULE-2718961814; AC1L1A8H; MolPort-001-769-006; Epitope ID:143620; Pyruvic aldehyde solution, 35-45 wt. % in water 25g; 194597AC-5BFC-42EA-B6C8-DA2E5FAA13AF; Methylglyoxal solution, ~40% in H2O; CHEBI:17158 | C3H4O2 | 72.06 g/mol | CC(=O)C=O |
| TCMBANKIN019671 | Artonin E | 4H,8H-Benzo(1,2-b:3,4-b')dipyran-4-one, 5-hydroxy-8,8-dimethyl-3-(3-methyl-2-butenyl)-2-(2,4,5-trihydroxyphenyl)-; 5'-Hydroxymorusin; 5'-hydroxymorusin; artonin e; 5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)-2-(2,4,5-trihydroxyphenyl)pyrano[6,5-h]chromen-4-one; AIDS-095972; AIDS095972; 5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)-2-(2,4,5-trihydroxyphenyl)-4-pyrano[6,5-h]chromenone; artonin e ; 5-Hydroxy-8,8-dimethyl-3-(3-methyl-but-2-enyl)-2-(2,4,5-trihydroxy-phenyl)-8H-benzo[1,2-b:4,3-b']dipyran-4-one; 129683-93-8 | C25H24O7 | 436.45 | CC(=CCC1=C(OC2=C(C1=O)C(=CC3=C2C=CC(O3)(C)C)O)C4=CC(=C(C=C4O)O)O)C |
| TCMBANKIN019888 | glycyrrhisoflavanone | 7-hydroxy-3-(8-hydroxy-2,2-dimethylchromen-6-yl)-5-methoxy-2,3-dihydrochromen-4-one; LMPK12050506; SCHEMBL756083; Glycyrrhisoflavanone; 7,8'-dihydroxy-5-methoxy-2',2'-dimethyl-[3,6'-bi-2h-I-benzopyran]-4(3h)-one; AC1NSW0F | C21H20O6 | 368.4 g/mol | CC1(C=CC2=C(O1)C(=CC(=C2)C3COC4=C(C3=O)C(=CC(=C4)O)OC)O)C |
| TCMBANKIN019942 | vitamin e | vitamin-e; LS-187838; alpha-tocopherol; tocopherol; β-Tocopherol; α-tocopher | C29H50O2 | 430.7 g/mol | CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C |
| TCMBANKIN020033 | (2S)-6-(2,4-dihydroxyphenyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofuro[3,2-g]chromen-7-one | 6-(2,4-Dihydroxyphenyl)-2-(1-hydroxy-1-methylethyl)-4-methoxy-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one; 6-(2,4-Dihydroxy-phenyl)-2-(1-hydroxy-1-methyl-ethyl)-4-methoxy-2,3-dihydro-furo[3,2-g]chromen-7-one; (2S)-6-(2,4-dihydroxyphenyl)-2-(1-hydroxy-1-methylethyl)-4-methoxy-2,3-dihydrofuro[3,2-g]chromen-7-one; InChI=1/C21H20O7/c1-21(2,25)18-8-14-16(27-18)9-17-13(19(14)26-3)7-12(20(24)28-17)11-5-4-10(22)6-15(11)23/h4-7,9,18,22-23,25H,8H2,1-3H; (2S)-6-(2,4-dihydroxyphenyl)-2-(1-hydroxy-1-methyl-ethyl)-4-methoxy-2,3-dihydrofuro[3,2-g]chromen-7-one; 7H-furo[3,2-g][1]benzopyran-7-one, 6-(2,4-dihydroxyphenyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-; 6-(2,4-dihydroxyphenyl)-2-(1-hydroxy-1-methylethyl)-4-methoxy-2,3-dihydro-7H-furo[3,2-g]chromen-7-one | 384.41 | ||
| TCMBANKIN020048 | glycyroside | Glycyroside; LMPK12050024; Formononetin 7-O-apiosyl-(1->2)-glucoside | C27H30O13 | 562.52 | COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)OC4C(C(C(C(O4)CO)O)O)OC5C(C(CO5)(CO)O)O |
| TCMBANKIN020283 | methyl 2-hydroxy-3,4-dimethoxybenzoate | ODKFBQCYKKPNLJ-UHFFFAOYSA-N; 2-hydroxy-3,4-dimethoxy-benzoic acid methyl ester; methyl 2-hydroxy-3,4-dimethoxy-benzoate; 6395-23-9; methyl 2-hydroxy-3,4-dimethoxy benzoate; SCHEMBL1434290; 2-hydroxy-3,4-dimethoxybenzoic acid methyl ester; Methyl 2-hydroxy-3,4-dimethoxy benzoate; Methyl 3,4-dimethoxy-2-hydroxybenzoate; AC1NSYFM; 3,4-Dimethoxysalicylic acid methyl ester | C10H12O5 | 212.2 | COC1=C(C(=C(C=C1)C(=O)OC)O)OC |
| TCMBANKIN020760 | glycyrrhetol | (18alpha)-3beta,30-Dihydroxyolean-12-en-11-one | C30H48O3 | 456.7 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)CO)C)C)C)C |
| TCMBANKIN020954 | 7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromone | 7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromen-4-one; 7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)-4-chromenone | 390.51 | ||
| TCMBANKIN021742 | 7,4'-Dihydroxyflavone | 4',7-Dihydroxyflavone; SPECTRUM1500721; FLAVONE, 4',7-DIHYDROXY-; 7,4'- dihydroxyflavone; NCGC00096029-01; ST5309369; ZINC00057658; 7-hydroxy-2-(4-hydroxyphenyl)-4-chromenone; 2196-14-7; 4H-1-Benzopyran-4-one, 7-hydroxy-2-(4-hydroxyphenyl)-; 7-hydroxy-2-(4-hydroxyphenyl)chromen-4-one; KBioGR_001900; Spectrum4_001280; C12123; 5-18-04-00083 (Beilstein Handbook Reference); BRN 0224356; 7-hydroxy-2-(4-hydroxyphenyl)chromone | C15H10O4 | 254.24 | C1=CC(=C(C=C1O)O)C2=CC(=O)C3=C(O2)C=C(C=C3)O |
| TCMBANKIN021778 | 2,2-DIMETHYLPENTANE | EINECS 209-680-5; Pentane, 2,2-dimethyl-; 590-35-2; FR-2131; InChI=1/C7H16/c1-5-6-7(2,3)4/h5-6H2,1-4H; 41060_FLUKA; 110671_ALDRICH | C7H16 | 100.2 | CCCC(C)(C)C |
| TCMBANKIN021939 | 3,4-Dicaffeoylquinic acid | 3,4-dicaffeoylquinic acid | C25H24O12 | 516.45 | C1C(C(C(CC1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O |
| TCMBANKIN021988 | 5,7-dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromone | 5,7-dihydroxy-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-2-(3,4,5-trihydroxyphenyl)-4-chromenone; 5,7-dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; 5,7-dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; 5,7-dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one | C14H28O2 | 228.37 | CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C(=C4)O)O)O)O)O)O |
| TCMBANKIN022287 | neohancoside a | [(R)-1,5-Dimethyl-1-vinyl-4-hexenyl]6-O-(beta-D-xylo-pentopyranosyl)-beta-D-glucopyranoside | C21H36O10 | 448.5 g/mol | CC(=CCCC(C)(C=C)OC1C(C(C(C(O1)COC2C(C(C(CO2)O)O)O)O)O)O)C |
| TCMBANKIN022330 | 12-methyltetradecanoate | 12-methyltetradecanoic acid methyl ester; tetralosanoic acid,12-methyl-,methyl ester | C7H3N3O8 | 257.11 | CCC(C)CCCCCCCCCCC(=O)[O-] |
| TCMBANKIN022549 | shinpterocarpin | C20H18O4 | 322.35 | CC1(C=CC2=C(O1)C=CC3=C2OCC4C3OC5=C4C=CC(=C5)O)C | |
| TCMBANKIN022773 | 6'-o-acetylloganicacid | C18H26O11 | 418.4 g/mol | CC1C(CC2C1C(OC=C2C(=O)O)OC3C(C(C(C(O3)COC(=O)C)O)O)O)O | |
| TCMBANKIN023247 | 2-methyl-5-propyl nonane | 2-methyl-5-propyl -nonane; 2-Methyl-5-propyl nonane; NONANE,2-METHYL-5-PROPYL-; CABCROIGBFQLHZ-UHFFFAOYSA-N; 31081-17-1; Nonane, 2-methyl-5-propyl-; AC1LC12C; 2-methyl-5-propylnonane; 2-Methyl-5-propylnonane #; 2-Methyl-5-propylnonane | C13H28 | 184.36 | CCCCC(CCC)CCC(C)C |
| TCMBANKIN023350 | Isolicoflavonol | LMPK12111984; 94805-83-1; AIDS-060353; AIDS060353; CHEMBL457679; SR-01000765807; 5,7,4'-trihydroxy-3'-prenylflavonol; MLS000697735; BDBM50251003; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-; HMS2271L11; 9577AF; cid_5318585; SR-01000765807-2; 3,5,7-Trihydroxy-2-[4-hydroxy-3-(3-methyl-2-butenyl)phenyl]-4H-1-benzopyran-4-one, 9CI; 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromone; D0E5FV; AC1NSX1R; 4',5,7-Trihydroxy-3'-prenylflavonol; ZINC13130924; PGCKDCPTJAQQSQ-UHFFFAOYSA-N; MolPort-039-052-689; isolicoflavonol; BG01067669; SMR000470986; SCHEMBL5614138; 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-4-chromenone; 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromen-4-one; 3,5,7-Trihydroxy-2-[4-hydroxy-3-(3-methyl-2-butenyl)phenyl]-4H-1-benzopyran-4-one | C20H18O6 | 354.35 | CC(=CCC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)C |
| TCMBANKIN023632 | 3'-Methoxyglabridin | AC1NSY37; 3'-methoxyglabridin; 4-(8,8-dimethyl-3,4-dihydro-2H-pyrano[2,3-f]chromen-3-yl)-2-methoxybenzene-1,3-diol; SCHEMBL10730635; LMPK12080018 | C21H22O5 | 354.4 g/mol | CC1(C=CC2=C(O1)C=CC3=C2OCC(C3)C4=C(C(=C(C=C4)O)OC)O)C |
| TCMBANKIN024042 | Araboglycyrrhizin_qt | 470.76 | |||
| TCMBANKIN024347 | viscotoxin a3 | ||||
| TCMBANKIN024492 | dehydroglyasperins C | 340.4 | |||
| TCMBANKIN024594 | icos-5-enoic acid | (E)-icos-5-enoic acid; 5E-eicosenoic acid; LMFA01030370 | C20H38O2 | 310.5 g/mol | CCCCCCCCCCCCCCC=CCCCC(=O)O |
| TCMBANKIN025070 | Gancaonin R | 5-[2-(3,4-dihydroxyphenyl)ethyl]-4,6-bis(3-methylbut-2-enyl)benzene-1,3-diol; gancaonin r; AIDS-095962; 4-{2-[2,6-Bis((2E)-3-methylbut-2-enyl)-3,5-dihydroxyphenyl]ethyl}benzene-1,2-diol; 4-(2-(2,6-Bis((2E)-3-methylbut-2-enyl)-3,5-dihydroxyphenyl)ethyl)benzene-1,2-diol; 134958-53-5; 5-[2-(3,4-dihydroxyphenyl)ethyl]-4,6-bis(3-methylbut-2-enyl)resorcinol; AIDS095962 | C24H30O4 | 382.49 | CC(=CCC1=C(C(=C(C=C1O)O)CC=C(C)C)CCC2=CC(=C(C=C2)O)O)C |
| TCMBANKIN025200 | (2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one | ZINC00519174; (2R)-7-hydroxy-2-(4-hydroxyphenyl)-4-chromanone | C15H12O4 | 256.25 | |
| TCMBANKIN025599 | ISOHEPTANE | NSC 24840; D 726; EINECS 250-610-8; Hexane, 2-methyl-; NSC24840; M49704_ALDRICH; 591-76-4; FR-2384; 67360_FLUKA; EINECS 209-730-6; 2-Methylhexane; 31394-54-4 | C7H16 | 100.2 | CCCCC(C)C |
| TCMBANKIN026129 | (E)-dodec-2-ene | 68991-52-6; (2E)-2-Dodecene; 2-Dodecene, (E)-; Alkenes, C10-16 | C12H24 | 168.32 g/mol | CCCCCCCCCC=CC |
| TCMBANKIN026336 | 3-[4,6-dihydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-chromone | 3-[4,6-dihydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxychromen-4-one; 3-[4,6-dihydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-4-chromenone; 3-[4,6-dihydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-chromen-4-one | C21H20O6 | 368.38 | |
| TCMBANKIN026482 | Docosyl caffeate | docosyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; ST24046665; DOCOSYL (2E)-3-(3,4-DIHYDROXYPHENYL)PROP-2-ENOATE; MolPort-023-298-972; ZINC73220104; AKOS022184902; 2-Propenoic acid,3-(3,4-dihydroxyphenyl)-, docosyl ester, (2E)-; 3,4-Dihydroxycinnamic acid docosyl ester; Docosyl caffeate, analytical standard; W2091; docosyl caffeate; 28593-92-2; 3,4-Dihydroxybenzeneacrylic acid docosyl ester; CHEMBL1933863; SCHEMBL883452; 9375AF; AK104300; Docosyl 3-(3,4-dihydroxyphenyl)acrylate; Caffeic acid docosyl ester; 50432-89-8; AC1NSUY6 | C31H52O4 | 488.74 | CCCCCCCCCCCCCCCCCCCCCCOC(=O)C=CC1=CC(=C(C=C1)O)O |
| TCMBANKIN027275 | Nortangeretin | SMR000528344; 5,6,7,8-tetrahydroxy-2-(4-hydroxyphenyl)chromen-4-one; 2-(4-Hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one; 5,6,7,8-tetrahydroxy-2-(4-hydroxyphenyl)-4-chromenone; 5,6,7,8-tetrahydroxy-2-(4-hydroxyphenyl)chromone; 4H-1-Benzopyran-4-one, 5,6,7,8-tetrahydroxy-2-(4-hydroxyphenyl)-; 5,6,7,8,4'-Pentahydroxyflavone; NSC76988; NSC 76988; MLS000736839; C15031; 577-26-4 | C15H10O7 | 302.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)O)O)O)O)O |
| TCMBANKIN027545 | kanzonols X | 394.55 | |||
| TCMBANKIN027667 | isotrilobine | CHEMBL503363; SMR001397249; cid_44143978; MLS002473157; BDBM79337 | C36H36N2O5 | 576.7 g/mol | CN1CCC2=CC(=C3C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(O3)C=C8CCN7C)O4)OC)OC |
| TCMBANKIN028431 | liquiritigenin4'-o-β-d-apio-d-furanosyl(1→2)-β-d-glucopyranoside | ||||
| TCMBANKIN028979 | methyl-24-hydroxyglycyrrhetate | methyl (2S,4aS,6bR,9S,10S,12aS,14bR)-10-hydroxy-9-(hydroxymethyl)-2,4a,6a,6b,9,12a-hexamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate; AC1NSYFV | CC12CCC(CC1C3=CC(=O)C4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)O)C)(C)C(=O)OC | ||
| TCMBANKIN029162 | 18beta-glycyrrhetinic acid | AJ-72559; Rhetinic Acid; C02283; GLYCYRRHETINIC ACID; 18-beta-Glycyrrhetinic acid; 1449-05-4; Glycyrrhetic acid; Hidermart; CHEMBL230006; SMR000058239; SR-01000721867-5; NCGC00142473-03; 18beta-Glycyrrhetinic acid, purum, >=97.0% (T); UNII-P540XA09DR; Enoxolone (Glycyrrhetin); 107420-91-7; Enoxolone, Glycyrrhetinic acid; CCRIS 3962; LMPR0106150014; 18beta-Glycyrrhetic acid; 4-10-00-03775 (Beilstein Handbook Reference); BB_NC-0599; HMS2233P23; LS-7417; (3?)-3-Hydroxy-11-oxoolean-12-en-30-oic acid; Opera_ID_1048; D0U8IF; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; NSC-35350; Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo- (8CI); AC-1925; Glycyrrhetinic acid; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxidanyl-13-oxidanylidene-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; HY-N0180; Arthrodont; Hidermart (TN); DTXSID9020669; SR-01000721867-3; MLS002207101; Enoxolona; Glycyrrhetinic acid (JAN); A-Hydroxy-11-oxoolean-12-en-30-olic acid; SR-01000721867-6; Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-; (3beta)-3-hydroxy-11-oxoolean-12-en-30-oic acid; subglycyrrhelinic acid; SCHEMBL18540; 471-53-4; Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-; BG01168029; FT-0082445; BX-1; Glycyrrhetin; D00156; NCGC00017244-03; 202522-39-2; 18-beta-Glycyrrhetic acid; SR-01000721867-4; Enoxolonum [INN-Latin]; SBB006496; GM-1658; Q-201057; NSC-35347; NSC 35347; (5S,8S,15S,18S,1R,2R,10R,14R,20R)-18-hydroxy-1,2,5,8,15,19,19-heptamethyl-13-o xopentacyclo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-8-carboxylic acid; alpha-Glycyrrhetinic acid; Tox21_112726; 130100-EP2295411A1; ZINC19203131; Biosone; D08LGJ; Bio-0549; Enoxolone; 18beta-Glycyrrhetinic acid; 3?-Hydroxy-11-oxo-18?,20?-olean-12-en-29-oic acid; Enoxolone (Glycyrrhetinic acid); 50510_FLUKA; BDBM50233538; Uralenic acid; NCGC00017244-04; P540XA09DR; 18beta-glycyrrhetic acid; C30H46O4; Jintan; Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo-; CAS-471-53-4; Tox21_200799; SR-01000721867; Enoxolone (INN); MLS001146949; MLS000028748; [(125)I] RB129; G10105_ALDRICH; (3beta,20beta)-3-Hydroxy-11-oxo-olean-12-en-29-oic acid; s2296; CCG-208506; 8055-71-8; EINECS 207-444-6; (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid; Enoxolona [INN-Spanish]; GlycyrrhetinicAcid; 18b-Glycyrrhetic acid; AC1L1UIT; 130100-EP2269977A2; KS-1262; Glycyrrhetinate; Glycyrrhetinic acid [JAN]; (3alpha,5xi,8alpha,9xi,17alpha,18xi)-3-hydroxy-11-oxoolean-12-en-29-oic acid; BC201656; Enoloxone; Enoxolone [INN:BAN:DCF]; 18 beta-glycyrrhetinic acid; 3beta-Hydroxy-11-oxo-18beta,20beta-olean-12-en-29-oic acid; enoxolone; DSSTox_RID_75722; 18 beta-Glycyrrhetintic Acid; DSSTox_CID_669; 3-Glycyrrhetinic acid; 3beta-hydroxy-11-oxoolean-12-en-29-oic acid; NCGC00181115-01; Enoxolone; STX-352; AKOS016036757; 15301-63-0; G0149; MFCD00003706; ST24038257; Enoxolone, European Pharmacopoeia (EP) Reference Standard; ST056310; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-13-keto-2,4a,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; AKOS015960428; 471G534; NCGC00258353-01; DB13089; Tox21_110804; CBW; DSSTox_GSID_20669; D0F6IV; MolPort-002-507-130; A827163; (3beta,5beta,14beta)-3-Hydroxy-11-Oxoolean-12-En-29-Oic Acid; 18beta-Glycyrrhetinic acid, 97%; CHEBI:30853; AC-8906; AN-14462; API0002854; BRN 2229654; Glyciram; 18beta-Glycyrrhetinic acid; MCULE-4676598997; 3beta-Hydroxy-11-oxoolean-12-en-30-oic acid; 3-beta-Hydroxy-11-oxoolean-12-en-30-oic acid; BG00824432; Enoxolone [BAN:DCF:INN]; CS-W020624; S00284; Enoxolonum; 299198-00-8 | C30H46O4 | 470.68 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN029164 | (E)-1-(2,4-dihydroxyphenyl)-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one | C20H20O4 | 324.37 | ||
| TCMBANKIN029421 | Yinyanghuo D | 119240-82-3; 3'-Prenylnaringenin; (2S)-3'-(3,3-Dimethylallyl)-4',5,7-trihydroxyflavonone; AIDS071736; 5,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromen-4-one; Licoflavanone; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxy-3-(3-methyl-2-butenyl)phenyl)-, (S)-; yinyanghuo d; 5,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-4-chromenone; 5,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromone; AIDS-071736 | C20H20O5 | 340.37 | CC(=CCC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)C |
| TCMBANKIN029503 | isogosferol | 9-((2-Hydroxy-3-methyl-3-butenyl)oxy)-7H-furo(3,2-g)(1)benzopyran-7-one; AKOS032948613; Isogosferol; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-((2-hydroxy-3-methyl-3-butenyl)oxy)-; Isogospherol; 9-[(2-HYDROXY-3-METHYLBUT-3-EN-1-YL)OXY]FURO[3,2-G]CHROMEN-7-ONE; AC1L3XHE; MEGxp0_000940; 9-(2-hydroxy-3-methylbut-3-enoxy)furo[3,2-g]chromen-7-one; (+)-Isogospherol; 53319-52-1; RTUPRHIHXSAWDP-UHFFFAOYSA-; InChI=1/C16H14O5/c1-9(2)12(17)8-20-16-14-11(5-6-19-14)7-10-3-4-13(18)21-15(10)16/h3-7,12,17H,1,8H2,2H3; SCHEMBL2468855 | C16H14O5 | 286.28 | CC(=C)C(COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)O |
| TCMBANKIN029776 | 4'-o-methyl leucopelargonidin-3-mono-glucofuranoside | 4'-o-methyl leucopelargonidin-3-mono-gluco-furanoside | C22H26O11 | COC1=CC=C(C=C1)C2C(C(C3=C(C=C(C=C3O2)O)O)O)OC4C(C(C(O4)C(CO)O)O)O | |
| TCMBANKIN029828 | glyyunnanprosapogenin d | AC1NSW0R; (2S,3S,4S,5R,6R)-6-[[2-carboxy-10-[(2R,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-11-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12-dodecahydropicen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | C42H62O16 | 822.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)O)C)C=CC5=C6CC(C(CC6(CCC53C)C)OC7C(C(C(C(O7)C(=O)O)O)O)O)(C)C(=O)O)C)C |
| TCMBANKIN030507 | (e)-1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(2,2-dimethyl-8-hydroxy-2h-benzo-pyran-6-yl)-2-propen-1-one | (e)-1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(2,2-dimethyl-8-hydroxy-2h-benzopyran-6-yl)-2-propen-1-one | C25H26O5 | CC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=CC(=C3C(=C2)C=CC(O3)(C)C)O)O)C | |
| TCMBANKIN030651 | neowilforine | C43H49NO17 | 849.96 | CC1CCC2=C(C=CC=N2)C(=O)OCC3(CC45C(C(C(C(C4(C(C(C3C5OC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C6=CC=CC=C6)OC1=O)C)C | |
| TCMBANKIN030693 | liquoric acid | liquoricacid | C30H44O5 | 484.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CC5C6(C4CC(C(C6)O5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN030741 | 3,22-Dihydroxy-11-oxo-delta(12)-oleanene-27-alpha-methoxycarbonyl-29-oic acid | 123914-44-3; Olean-12-ene-27,29-dioic acid, 3,22-dihydroxy-11-oxo-, gamma-lactone, methyl ester, (3beta,20alpha,22alpha)- | C31H44O6 | 512.68 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C(=O)OC)C)C |
| TCMBANKIN031438 | gloeosteretriol | C15H26O3 | 254.36 g/mol | CC1C(CC2(C1(C3CC(CC3(C2)O)(C)C)C)O)O | |
| TCMBANKIN031578 | kanzonols L | 490.64 | |||
| TCMBANKIN031645 | glyasperins Z | 340.45 | |||
| TCMBANKIN031982 | glisoflavanone | BDBM50134719; 3-[2,4-Dihydroxy-3-(3-methyl-but-2-enyl)-phenyl]-5,7-dihydroxy-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one; AC1LA3F4; 3-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-4h-chromen-4-one; CTK5J8804; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-6-(3-methylbut-2-enyl)chroman-4-one; CHEMBL3746555; 3-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one; 3',6'-Diprenyldalbergioidin; Glisoflavanone; SCHEMBL5614193 | C25H28O6 | 424.5 g/mol | CC(=CCC1=C(C=CC(=C1O)C2COC3=C(C2=O)C(=C(C(=C3)O)CC=C(C)C)O)O)C |
| TCMBANKIN032054 | (E)-3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-1-(2,4-dihydroxyphenyl)prop-2-en-1-one | 340.4 | |||
| TCMBANKIN032327 | Gancaonin U | AIDS095965; gancaonin u; 8-(3-Methyl-but-2-enyl)-6-((E)-3-methyl-but-2-enyl)-9,10-dihydro-phenanthrene-2,3,5,7-tetraol; 134958-56-8; AIDS-095965; 6,8-bis(3-methylbut-2-enyl)-9,10-dihydrophenanthrene-2,3,5,7-tetrol | C24H28O4 | 380.48 | CC(=CCC1=C2CCC3=CC(=C(C=C3C2=C(C(=C1O)CC=C(C)C)O)O)O)C |
| TCMBANKIN032898 | licochalcone G | C21H22O5 | 354.4 g/mol | CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=C(C=C(C=C2)O)O)OC)O | |
| TCMBANKIN033153 | 3-(2,4-dihydroxyphenyl)-8-(1,1-dimethylprop-2-enyl)-7-hydroxy-5-methoxy-coumarin | 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-8-(2-methylbut-3-en-2-yl)chromen-2-one; 3-(2,4-dihydroxyphenyl)-8-(1,1-dimethylprop-2-enyl)-7-hydroxy-5-methoxy-chromen-2-one; 3-(2,4-dihydroxyphenyl)-8-(1,1-dimethylprop-2-enyl)-7-hydroxy-5-methoxy-2-chromenone | 368.41 | ||
| TCMBANKIN033202 | liquiritigenin-7,4'-diglucoside | liquiritigenin 7,4'-diglucoside; AC1NSXLJ; 7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one; 4',7-Bis(beta-D-glucopyranosyloxy)flavanone | C27H32O14 | 580.5 g/mol | C1C(OC2=C(C1=O)C=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)C4=CC=C(C=C4)OC5C(C(C(C(O5)CO)O)O)O |
| TCMBANKIN033218 | Eurycarpin A | eurycarpin a; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-chromen-4-one; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxychromen-4-one; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-chromone; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-7-hydroxy-4-chromenone | C20H18O5 | 338.4 g/mol | CC(=CCC1=C(C=CC(=C1O)C2=COC3=C(C2=O)C=CC(=C3)O)O)C |
| TCMBANKIN033656 | (E)-1-(2,4-dihydroxyphenyl)-3-(2,2-dimethylchromen-6-yl)prop-2-en-1-one | (E)-1-(2,4-dihydroxyphenyl)-3-(2,2-dimethyl-6-chromenyl)prop-2-en-1-one | 322.38 | ||
| TCMBANKIN033679 | Glepidotin B | 87440-56-0; C09753; glepidotin b; (2R,3R)-3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-chroman-4-one; (2R,3R)-3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-4-chromanone; (2R,3R)-3,5,7-trihydroxy-8-(3-methylbut-2-enyl)-2-phenylchroman-4-one | C20H20O5 | 340.37 | CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(C(O2)C3=CC=CC=C3)O)C |
| TCMBANKIN033792 | narwedine | C17H19NO3 | 285.34 g/mol | CN1CCC23C=CC(=O)CC2OC4=C(C=CC(=C34)C1)OC | |
| TCMBANKIN033809 | Gancaonin H | 5,7,8'-Trihydroxy-2',2'-dimethyl-6-(3-methyl-but-2-enyl)-2'H-(3,6')bi(1-benzopyranyl)-4-one; 126716-35-6; AIDS095922; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-6-chromenyl)-6-(3-methylbut-2-enyl)-4-chromenone; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethylchromen-6-yl)-6-(3-methylbut-2-enyl)chromen-4-one; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-chromen-6-yl)-6-(3-methylbut-2-enyl)chromone; 5,7,8'-Trihydroxy-2',2'-dimethyl-6-(3-methyl-but-2-enyl)-2'H-[3,6']bi[1-benzopyranyl]-4-one; AIDS-095922; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-chromen-6-yl)-6-(3-methylbut-2-enyl)chromen-4-one | C25H24O6 | 420.45 | CC(=CCC1=C(C2=C(C=C1O)OC=C(C2=O)C3=CC4=C(C(=C3)O)OC(C=C4)(C)C)O)C |
| TCMBANKIN033963 | 1-Methoxyficifolinol | AIDS-096029; (6aR,11aR)-1-methoxy-2,8-bis(3-methylbut-2-enyl)-6a,11a-dihydro-6H-benzofurano[3,2-c]chromene-3,9-diol; (6aR,11aR)-1-Methoxy-8-(3-methyl-but-2-enyl)-2-(3-methyl-but-2-enyl)-6a,11a-dihydro-6H-benzofuro[3,2-c][1]benzopyran-3,9-diol; 6H-benzofuro[3,2-c][1]benzopyran-3,9-diol, 6a,11a-dihydro-1-methoxy-2,8-bis(3-methyl-2-butenyl)-, (6aR,11aR)-; InChI=1/C26H30O5/c1-14(2)6-8-16-10-18-19-13-30-23-12-21(28)17(9-7-15(3)4)25(29-5)24(23)26(19)31-22(18)11-20(16)27/h6-7,10-12,19,26-28H,8-9,13H2,1-5H3/t19-,26+/m0/s; rel-(6aR,11aR)-1-methoxy-2,8-bis(3-methylbut-2-en-1-yl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol; AIDS096029; (6aR,11aR)-1-methoxy-2,8-bis(3-methylbut-2-enyl)-6a,11a-dihydro-6H-[1]benzoxolo[3,2-c]chromene-3,9-diol | C27H30O14 | 578.52 | CC(=CCC1=CC2=C(C=C1O)OC3C2COC4=C3C(=C(C(=C4)O)CC=C(C)C)OC)C |
| TCMBANKIN033966 | licochalconeD | licochalcone d | C21H22O5 | 354.4 | CC(=CCC1=C(C=CC(=C1)C(=O)C=CC2=C(C(=C(C=C2)O)O)OC)O)C |
| TCMBANKIN033976 | (2S)-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8,8-dimethyl-2,3-dihydropyrano[2,3-f]chromen-4-one | 157414-03-4 | C25H26O4 | 390.47 | CC(=CCC1=C(C=CC(=C1)C2CC(=O)C3=C(O2)C4=C(C=C3)OC(C=C4)(C)C)O)C |
| TCMBANKIN034139 | uralsaponin B | uralsaponin b | C42H62O16 | 822.93 | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C |
| TCMBANKIN034324 | kanzonols W | 336.36 | |||
| TCMBANKIN034479 | (E)-1-butoxyhex-2-ene | 2-Hexene, 1-butoxy-, (E)-; (2E)-1-Butoxy-2-hexene | C10H20O | 156.27 | CCCCOCC=CCCC |
| TCMBANKIN034632 | amylum | ARGO brand corn starch; Food starch, unmodified; Maranta; Clearjel; Amylum; W-13 Stabilizer; Claro 5591; Starch, unmodified; Starch, pregelatinized; Starken; Rice starch; Farinex 100; Aquapel (polysaccharide); Penford Gum 380; Sta-RX 1500; Sorghum gum; Starch, wheat; Trogum; EINECS 232-679-6; Remyline Ac; LS-54975; Starch, corn; Amylomaize VII; Sago starch; Food starch; Meluna; Starch mucilage; Melojel; Maizena; Tapon; Wheat starch, unmodified; Starch [USAN]; W-Gum; Starch dust; CPC 6448; Cornstarch; Amyla; Genvis; Arrowroot starch; Corn starch; Starch, converted; Starch, rice; Starch, potato; Staramic 747; HRW 13; CPC 3005; Galactasol A; OK PRE-GEL; Keestar; Tapioca starch; Amaizo W 13; Wheat starch | C27H48O20 | 692.7 g/mol | CC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)OC)O)O)OC4C(C(C(C(O4)CO)OC)O)O)O)O)O)O |
| TCMBANKIN035082 | Kanzonol E | C25H24O4 | 388.5 g/mol | CC(=CCC1=CC2=C(C=C1O)OC(=CC2=O)C3=CC4=C(C=C3)OC(C=C4)(C)C)C | |
| TCMBANKIN035110 | phebalosin | 7-methoxy-8-(3-prop-1-en-2-yloxiran-2-yl)chromen-2-one; AC1NSZK9; MolPort-005-945-718; MLS004491682; MCULE-8031040658; DG261A2; SCHEMBL14315516; 8-(3-isopropenyloxiran-2-yl)-7-methoxy-chromen-2-one; AK-693/41507039; NCGC00385172-01!7-methoxy-8-(3-prop-1-en-2-yloxiran-2-yl)chromen-2-one; phebalosin ; 7-Methoxy-8-(3-isopropenyloxiranyl)-2H-1-benzopyran-2-one; SMR003288649 | C15H14O4 | 258.27 g/mol | CC(=C)C1C(O1)C2=C(C=CC3=C2OC(=O)C=C3)OC |
| TCMBANKIN035224 | glyuranolide | Glyuranolide; methyl 11-hydroxy-2,6,10,10,14,21-hexamethyl-16,22-dioxo-23-oxahexacyclo[19.2.1.0;{2,19}.0;{5,18}.0;{6,15}.0;{9,14}]tetracos-17-ene-5-carboxylate | C31H44O6 | 512.68 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C(=O)OC)C)C |
| TCMBANKIN035334 | glyasperins D | C22H26O5 | 370.44 | ||
| TCMBANKIN035354 | Pentadecanol | CS-W004295; EINECS 267-006-5; UNII-2C8M6XLB5C component REIUXOLGHVXAEO-UHFFFAOYSA-N; MolPort-003-932-224; MFCD00004759; pentadecanol; 1-PENTADECANOL; 333QVA4G2Q; DSSTox_GSID_27270; CHEMBL26561; AK126490; LMFA05000194; 39433-03-9; STL453722; UNII-333QVA4G2Q; AI3-33881; Neodol 5; AC1L1ZIC; ST2419772; NCGC00259248-01; Pentadecyl alcohol; InChI=1/C15H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16/h16H,2-15H2,1H; Tox21_300553; EBD2204704; NE10352; C12-18 alcohols; EINECS 211-107-9; F0001-1704; n-1-Pentadecanol; 1-Pentadecanol, 99%; P0036; UNII-135SF8G7FQ component REIUXOLGHVXAEO-UHFFFAOYSA-N; KB-259209; 76520_FLUKA; 60650-33-1; CHEBI:77468; KS-000011U9; 412228_ALDRICH; SCHEMBL29548; ZINC38141455; n-Pentadecanol; 67762-25-8; NCGC00254478-01; (C12-C18)-Alkyl alcohol; 1-pentadecanol (ACD/Name 4.0); NCGC00164169-02; 629-76-5; I14-19383; pentadecan-1-ol;; FT-0608196; NSC-66446; RTR-021678; pentadecan-1-ol; Pentadecanol-(1); NSC66446; DSSTox_RID_78381; TR-021678; Tox21_201699; ACMC-1CK30; 39457-30-2; DTXSID0027270; NCGC00164169-01; CAS-629-76-5; CTK1C3820; NCGC00164169-03; BP-30139; 6305AF; Alcohols, C12-18; n-pPentadecanol; ANW-34487; 1-Pentadecanol; C15H32O; 1991DA79-7140-48B0-9F03-1E3D88AC4F28; TRA0077159; REIUXOLGHVXAEO-UHFFFAOYSA-N; 39387-31-0; n-pentadecyl alcohol; 63393-83-9; NSC 66446; DSSTox_CID_7270; TL8004341; 31389-11-4; AKOS009031435 | C15H32O | 228.41 g/mol | CCCCCCCCCCCCCCCO |
| TCMBANKIN035749 | neoliquiritin | LMPK12140022; Neoliquiritin | C21H22O9 | 418.39 | C1C(OC2=C(C1=O)C=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)C4=CC=C(C=C4)O |
| TCMBANKIN035868 | 3,4,3',4'-Tetrahydroxy-2-methoxychalcone | C16H14O6 | 302.28 g/mol | COC1=C(C=CC(=C1O)O)C=CC(=O)C2=CC(=C(C=C2)O)O | |
| TCMBANKIN035914 | methyl-24-hydroxy-11-deoxoglycyrrhetate | AC1NSYFJ; methyl (2S,4aS,6bR,9S,10S,12aR,14bR)-10-hydroxy-9-(hydroxymethyl)-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-2-carboxylate | CC12CCC(CC1C3=CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)O)C)(C)C(=O)OC | ||
| TCMBANKIN035970 | (2R)-1-[2,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]propan-1-one | 410.55 | |||
| TCMBANKIN036038 | gancaonin T | gancaonin t | C24H30O5 | 398.49 | CC(=CCC1=C(C2=C(C=C1O)OC(C(C2)O)(C)C)CCC3=CC(=C(C=C3)O)O)C |
| TCMBANKIN036663 | liquiriligenin | ||||
| TCMBANKIN036829 | ursolic acid | ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 | C30H48O3 | 456.7 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-] |
| TCMBANKIN036837 | vitexin | 49513_FLUKA; vitexin ; vitexin-7-olate anion; Flavone, 8-D-glucosyl-4',5,7-trihydroxy-; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; vitexin-7-olate; vitex-in; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; 8-beta-D-Glucopyranosyl-apigenin; 521-33-5; CHEBI:16954; 8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Vitexin; vitexin-7-olate(1-); 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; Apigenin 8-C-glucoside; 8C-hexosyl apigenin; (1S)-1,5-anhydro-1-[5-hydroxy-2-(4-hydroxyphenyl)-7-oxido-4-oxo-4H-chromen-8-yl]-D-glucitol; CHEBI:57963; (1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-beta-D-glucopyranosyl-2-(4-hydroxyphenyl)-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-.beta.-D- glucopyranosyl-2-(4-hydroxyphenyl)-; 8-C-beta-glucopyranosylapigenin; 4H-1-Benzopyran-4-one, 8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-; NCGC00163642-01; C01460; EINECS 222-963-8; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; vitexin anion; 3681-93-4; AIDS026705; AIDS-026705 | C21H20O10 | 432.378 | c1([H])c(C2=C([H])C(c3c(c([C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])c(O[H])c([H])c3O[H])O2)=O)c([H])c([H])c(O[H])c1[H] |
| TCMBANKIN036840 | protocatechuic acid | 3,4-Dihydroxybenzoic acid; MLS000737807; c0120; 4-Carboxy-1,2-dihydroxybenzene; InChI=1/C7H6O4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H,(H,10,11; NSC 16631; ZB000710; Benzoic acid, 3,4-dihydroxy-; 4,5-dihydroxybenzoate; 3,4-dihydrobenzoic acid; DHB; DB03946; AC1N59J2; CCRIS 6291; AIDS082396; Protocatehuic acid; BRN 1448841; protocatechuicacid; 3,4-dihydroxybenzoate; SMR000528167; D-3487; EINECS 202-760-0; 4,5-Dihydroxybenzoic acid; C00230; Catechol-4-carboxylic Acid; 3,4-DHBA; Protocatechuic acid polymer; CHEBI:36241; 2buv; 4-10-00-01459 (Beilstein Handbook Reference); AIDS-082396; 99-50-3; A846038; AIDS002961; Oxidative polymer of protocatechuic acid; 37580_FLUKA; AIDS-002961; 1ykp; Benzoic acid, 3,4-dihydroxy- (9CI); NSC16631; 3,4-bis(oxidanyl)benzoate; CHEBI:36062; 3, 4-Dihydroxybenzoic acid; TULIP017459 | C18H14O8 | 358.299 | c12c(O[C@]([H])(c3c([H])c([H])c(O[H])c(O[H])c3[H])[C@@]1([H])C(=O)O[H])c(O[H])c([H])c([H])c2\C([H])=C([H])\C(O[H])=O |
| TCMBANKIN036845 | isoquercitrin | BDBM84979; FT-0627504; ISOQUERCITRIN | C21H20O12 | 464.376 | C1(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])C(=O)c4c(c([H])c(O[H])c([H])c4O[H])O1 |
| TCMBANKIN036862 | Hispaglabridin B | 3386OSM882; CHEMBL464582; 2H-1-Benzopyran-5-ol, 6-(3,4-dihydro-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-2,2-dimethyl-, (R)-; 2H-1-Benzopyran-5-ol, 6-((3R)-3,4-dihydro-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-2,2-dimethyl-; 2H,8H-Benzo(1,2-b:3,4-b')dipyran, 2H-1-benzopyran-5-ol deriv.; hispaglabridin b; UNII-3386OSM882; 68978-02-9 | C25H26O4 | 390.5 g/mol | CC1(C=CC2=C(O1)C=CC(=C2O)C3CC4=C(C5=C(C=C4)OC(C=C5)(C)C)OC3)C |
| TCMBANKIN036866 | glycyrrhizic acid | glycyrrhizicacid; CS-W019908; Glycyrrhizic acid | C42H62O16 | 822.93 | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C |
| TCMBANKIN036867 | glycyrrhetinic acid | beta-Glycyrrhetic acid; glycyrrhetinicacid; 3-hydroxy-11-oxoolean-12-en-29-oate; (2S,4aS,6aS,6bR,10S,12aS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; LT00233150; Glycyrrhetic acid; Glycyrrhetinic; 3b-hydroxy-11-oxo-Olean-12-en-30-oic acid; 3-hydroxy-11-oxoolean-12-en-29-oic acid (ACD/Name 4.0); 18b-Glycyrrhetic acid; Glycyrrhetin; Glycyrrhetinate; 3b-Hydroxy-11-oxoolean-12-en-30-oic acid; 18b-Glycyrrhtinic acid; Biosone; 3b-Hydroxy-11-oxoolean-12-en-30-oate; 3-Glycyrrhetinic acid; SCHEMBL13144257; 18b-Glycyrrhetinic acid; NCGC00186652-01; 3b-hydroxy-11-oxo-Olean-12-en-30-oate; b-glycyrrhetic acid; (2S,4AS,6AS,6BR,10S,12AS)-10-HYDROXY-2,4A,6A,6B,9,9,12A-HEPTAMETHYL-13-OXO-3,4,5,6,7,8,8A,10,11,12,12B,14B-DODECAHYDRO-1H-PICENE-2-CARBOXYLIC ACID; a-glycyrrhetinic acid | C30H46O4 | 470.68 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN036868 | Glycycoumarin | AIDS-060354; MolPort-039-101-203; AKOS026674269; LMPK12160018; DTXSID20241630; AC1NSW00; glycycoumarin; AK168532; 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)-2-chromenone; AIDS060354; 3-(2,4-Dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methyl-2-butenyl)-2H-1-benzopyran-2-one, 9CI; 3-(2,4-Dihydroxy-phenyl)-7-hydroxy-5-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-2-one; 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)coumarin; SCHEMBL759406; 94805-82-0; BDBM50325943; 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chromen-2-one; ZINC15262009; CHEMBL1223642; CHEBI:69087; 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-en-1-yl)-2H-chromen-2-one | C21H20O6 | 368.38 | CC(=CCC1=C(C2=C(C=C1O)OC(=O)C(=C2)C3=C(C=C(C=C3)O)O)OC)C |
| TCMBANKIN036871 | Glabridin | AIDS-096010; 59870-68-7; 4-(3,4-Dihydro-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-1,3-benzenediol; C10421; 4-((R)-8,8-Dimethyl-3,4-dihydro-2H,8H-benzo[1,2-b:4,3-b']dipyran-3-yl)-benzene-1,3-diol; 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]benzene-1,3-diol; 1,3-Benzenediol, 4-(3,4-dihydro-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-, (R)-; AIDS096010; 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]resorcinol; glabridin | C20H20O4 | 324.37 | CC1(C=CC2=C(O1)C=CC3=C2OCC(C3)C4=C(C=C(C=C4)O)O)C |
| TCMBANKIN036888 | Pinocembrin | Spectrum5_000349; KBio3_002549; AIDS014893; (R)-5,7-Dihydroxy-2-phenylchroman-4-one; NCGC00017205-02; SDCCGMLS-0066749.P001; ZB000598; SpecPlus_000896; (-)-pinocembrin; pinocembrine; (2S)-5,7-dihydroxy-2-phenyl-4-chromanone; Spectrum_001879; AKOS030254805; KBio2_004969; URFCJEUYXNAHFI-CYBMUJFWSA-N; NCGC00017205-01; Spectrum3_001635; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (S)-(-)-; ST023293; 5,7-Dihydroxyflavanone; BSPBio_003329; ZINC00073693; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (2R)-; (S)-2,3-Dihydro-5,7-dihydroxy-2-phenyl-4H-1-benzopyran-4-one; AK582703; 206660-42-6; KBio2_007537; NCGC00142377-01; (2S)-5,7-dihydroxy-2-phenylchroman-4-one; TNP00071; Pinocembrin (6CI); NSC 279005; (2R)-5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one; SCHEMBL10080882; Oprea1_508274; (R)-PINOCEMBRIN; DivK1c_006992; (2R)-5,7-dihydroxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one; A836234; SPBio_001859; Spectrum2_001670; AIDS-014893; KBioSS_002406; KBio2_002401; CTK0J0172; AC1LDIB9; (2R)-5,7-bis(oxidanyl)-2-phenyl-2,3-dihydrochromen-4-one; N2094; NSC 661207; (2R)-5,7-dihydroxy-2-phenylchroman-4-one; ZINC4935; BDBM26666; 480-39-7; KBioGR_002249; DTXSID30349853; CHEMBL399249; pinocembrin; ST024705; C09827; KBio1_001936; (R)-5,7-dihydroxyflavanone; (2S)-5,7-dihydroxy-2-phenyl-chroman-4-one; (2R)-5,7-DIHYDROXY-2-PHENYL-2,3-DIHYDRO-1-BENZOPYRAN-4-ONE; NSC 43318; Spectrum4_001765 | C16H14O4 | 270.28 | c1([H])c([H])c([H])c([C@@]2([H])Oc(c([H])c(C([H])([H])O[H])c([H])c3O[H])c3C(=O)C2([H])[H])c([H])c1[H] |
| TCMBANKIN036913 | naringenin | (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; ZINC1785; Spectrum2_000325; 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (-)-Naringenin; SDCCGMLS-0066570.P001; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; MLS000574861; KBio2_000727; CHEBI:50201; HMS3468H18; ALBB-015405; NCGC00017346-01; BBL010488; AJ-08090; DivK1c_000118; BB 0261506; (S)-2,3-dihydo-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; CAS-480-41-1; KBio3_001454; SC-85987; 4H-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2R)-; AIDS-001417; NINDS_000118; SCHEMBL17166263; Spectrum3_000567; 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; (2R)-naringenin; (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromanone; BSPBio_001954; BB_NC-1001; MCULE-5852778653; NCGC00163598-01; BG01564988; MFCD03265520; naringenin ; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2S)-; (2R)-5,7,4'-trihydroxyflavone; AKOS004119880; CHEBI:17846; ST24036200; AC1LDI7C; KBioGR_000508; ZINC00156701; Phytochemistry 8: 127 (1969); R6691; Asahina; 4',5, 7-Trihydroxyflavanone; N1370; (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; C00509; 480-41-1; KBio2_003295; (2R)-4',5,7-trihydroxyflavanone; (+)-naringenin; Spectrum_000247; ZB000410; NAR; pelargidanon 1602; (R)-naringenin; IDI1_000118; STK801623; Spectrum5_001423; MolPort-002-507-277; Spectrum4_000124; 17654-19-2; KBio1_000118; KBioSS_000727; (+)-(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2R)-4',5,7-trihydroxyflavan-4-one; NCGC00016457-01; STOCK1N-05989; KBio2_005863; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; AIDS001417; BG00617674; TNP00287; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; SPECTRUM1500746; YSO1; SMR000156272; 4',5,7-triOH-Flavone; SPBio_000329 | C15H12O5 | 272.253 | c1(O[H])c([H])c([H])c([C@]2([H])Oc(c([H])c(O[H])c([H])c3O[H])c3C(=O)C2([H])[H])c([H])c1[H] |
| TCMBANKIN036914 | Morusin | 62596-29-6; HY-N0622; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)pyrano[2,3-h]chromen-4-one; Mulberrochromene; 2-(2,4-Dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methyl-2-butenyl)-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one; 4H,8H-Benzo(1,2-b:3,4-b')dipyran-4-one, 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methyl-2-butenyl)-; 2-(2,4-Dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methyl-2-butenyl)-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one, 9CI; NSC 649220; AC1NQYV1; AIDS030379; SCHEMBL2562778; LMPK12110912; MolPort-001-741-197; CHEBI:7005; ACon1_001205; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)pyrano[6,5-h]chromen-4-one; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-en-1-yl)-4H,8H-pyrano[2,3-f]chromen-4-one; DTXSID70211641; Morusin; HMS2271K05; C10106; MEGxp0_001039; BDBM50242014; BRD-K40169295-001-01-2; cid_5281671; N2266; AIDS-030379; CHEMBL464006; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-en-1-yl)-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one; NSC-649220; FT-0686661; SMR000470930; NSC649220; AKOS032962066; MLS000697591; TCMDC-124149; morusin ; W1523; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)-4-pyrano[6,5-h]chromenone; ZINC5195808; CS-6885; Morusin, 3 | C25H24O6 | 420.454 | c12c(C([H])=C([H])C(C([H])([H])[H])(C([H])([H])[H])O1)c(OC(c3c([H])c([H])c(O[H])c([H])c3O[H])=C(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C4=O)c4c(O[H])c2[H] |
| TCMBANKIN037131 | ononin | 4H-1-Benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-3-(4-methoxyphenyl)-; MEGxp0_000395; 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; LMPK12050014; 486-62-4; 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Formononetin glucoside; STOCK1N-14986; 75375_FLUKA; 3-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside; ACon1_000463; ZINC01081322; 3-(4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; CHEBI:7775; 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Ononin; C10509; Formononetin 7-O-glucoside; Formononetin-7-O-beta-D-glucopyranoside; Formononetin-7-glucoside | C22H22O9 | 430.405 | [C@@]1([H])(O[H])[C@]([H])(C([H])([H])O[H])O[C@]([H])(Oc2c([H])c([H])c(C(=O)C(c3c([H])c([H])c(OC([H])([H])[H])c([H])c3[H])=C([H])O4)c4c2[H])[C@@]([H])(O[H])[C@]1([H])O[H] |
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN037352 | Isoschaftoside | Apigenin 6-C-alpha-L-arabinopyranoside-8-C-beta-D-glucopyranoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]chromone; 4H-1-Benzopyran-4-one, 6-alpha-L-arabinopyranosyl-8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-; 52012-29-0; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one; LMPK12110243; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]chromen-4-one; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxy-2-tetrahydropyranyl]-4-chromenone; 5,7,4'-Trihydroxy-6-C-arabinoside-8-C-glucoside flavone; Isoschaftoside | 564.49 | ||
| TCMBANKIN037438 | Sigmoidin B | 5'-Prenyleriodictyol; LMPK12140397; J3.647.722I | 356.4 g/mol | ||
| TCMBANKIN037976 | 3'-(γ,γ-Dimethylallyl)-kievitone | 3'(γ,γ-dimethylallyl)-kievitone | 424.53 | ||
| TCMBANKIN038032 | formononetin | Oprea1_815287; AIDS027672; 7-hydroxy-3-(4-methoxyphenyl)-4H-benzopyran-4-one; Isoflavone, 7-hydroxy-4'-methoxy- (8CI); NCI60_042081; NCGC00095207-03; Oprea1_139748; NCIOpen2_005983; SDCCGMLS-0066428.P001; CHEBI:18088; TNP00176; 485-72-3; Formononetol; Isoflavone, 7-hydroxy-4'-methoxy-; 7-hydroxy-3-(4-methoxyphenyl)chromone; Spectrum2_000560; Formononetin; NSC 93360; EINECS 207-623-9; 47752_FLUKA; KBio2_000853; 7-Hydroxy-3-(4-methoxyphenyl)-4-benzopyrone; Spectrum5_000258; KBio3_001519; NSC93360; KBioSS_000853; Spectrum_000373; SPECTRUM102007; KBio2_005989; Biochanin B; KBioGR_001878; NCGC00017269-01; 7-Hydroxy-3-(4′-methoxyphenyl)-4H-benzopyran-4-one; formononetin ; 7-hydroxy-4'-methoxy-isoflavone; BSPBio_002299; ZINC00113304; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)- (9CI); SBB016445; Spectrum3_000660; 7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one; Spectrum4_001429; DivK1c_006319; KBio2_003421; SPBio_000639; NCGC00095207-01; KBio1_001263; AIDS-027672; 7-Hydroxy-4'-methoxyisoflavone; C00858; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-; NCGC00095207-02; SpecPlus_000223 | C16H12O4 | 268.264 | C1([H])=C(c2c([H])c([H])c(OC([H])([H])[H])c([H])c2[H])C(c3c(O1)c([H])c(O[H])c([H])c3[H])=O |
| TCMBANKIN038204 | ferulic acid | (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; caffeic acid 3-methyl ether; ferulicacid; A803063; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate; CJ-00500; ZB002373; ferulate; CHEBI:29749; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; 3-Methoxy-4-hydroxy-trans-cinnamate; (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoate; Ferulic Acid; AC1NUT2L; ferulic acid | C10H10O4 | 194.18 | COC1=C(C=CC(=C1)C=CC(=O)O)[O-] |
| TCMBANKIN038286 | medicarpin | (-)-Demethylhomopterocarpin; (6aR,11aR)-6a,11a-dihydro-9-methoxy-6H-benzofuro[3,2c][1]benzopyran-3-ol; Demethylhomopterocarpin; (-)-Medicarpin; AIDS031298; C10503; (-) Medicarpin; l-3-Hydroxy-9-methoxypterocarpan; NSC350085; (6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-ol; 6H-Benzofuro[3, 2-c][1]benzopyran-3-ol, 6a,11a-dihydro-9-methoxy-, (6aR-cis)-; NCI60_003118; (6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromen-3-ol; AIDS-031298; 6H-Benzofuro[3,2-c][1]benzopyran-3-ol, 6a,11a-dihydro-9-methoxy-, (6aR-cis)-; (l)-De-o-methylhomopterocarpan; (-)-3-Hydroxy-9-methoxypterocarpan; 3-Hydroxy-9-methoxypterocarpan, (-); MEGxp0_001319; 6H-Benzofuro[3,2-c][1]benzopyran-3-ol, 6a,11a-dihydro-9-methoxy-, cis-; (6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzoxolo[3,2-c]chromen-3-ol; medicarpin; CHEBI:16114; 32383-76-9; ACon1_001568 | C16H14O4 | 270.28 | c1(O[H])c([H])c(OC([H])([H])[C@@]([H])(c2c(c([H])c(OC([H])([H])[H])c([H])c2[H])O3)[C@@]34[H])c4c([H])c1[H] |
| TCMBANKIN038308 | isoliquiritin | MolPort-001-742-630; 7014-39-3; 5041-81-6; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-(beta-D-glucopyranosyloxy)phenyl)-, (2E)-; C16978; Q-100563; BDBM50362885; (E)-1-(2,4-dihydroxyphenyl)-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]prop-2-en-1-one; SCHEMBL676338; 4-beta-D-glucopyranosyloxy-2',4'-dihydroxy-trans-chalcone; I07-0258; Isoliquiritin; X1193; 2Y348H1V4W; MEGxp0_001945; YNWXJFQOCHMPCK-LXGDFETPSA-N; CHEMBL599763; UNII-2Y348H1V4W; AKOS015897131; X1167; AC1NSX26; BG01706425; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-[4-(.beta.-D-glucopyranosyloxy)phenyl]-, (2E)-; AK554321; AT-28971; 4-[(1E)-3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]phenyl beta-D-glucopyranoside; N1750; (E)-1-(2,4-dihydroxyphenyl)-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one; MFCD00272145; ZINC33832004; LMPK12120021; 4-(beta-D-Glucopyranosyloxy)-2',4'-dihydroxychalcone; AK544982; CHEBI:80839; Neoisoliquritin | C21H22O9 | 418.394 | c1([H])c(O[H])c(C(=O)\C([H])=C([H])\c2c([H])c([H])c(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])c([H])c2[H])c([H])c([H])c1O[H] |
| TCMBANKIN038633 | Gancaonin I | AIDS-095916; CHEMBL3808735; 4-[4,6-dimethoxy-5-(3-methylbut-2-enyl)benzofuran-2-yl]benzene-1,3-diol; 4-[4,6-dimethoxy-5-(3-methylbut-2-enyl)-1-benzofuran-2-yl]benzene-1,3-diol; gancaonin i; DTXSID90155275; AC1Q7B9P; ZINC5854532; 126716-36-7; MCULE-8882411958; 4-(4,6-Dimethoxy-5-(3-methyl-but-2-enyl)-benzofuran-2-yl)-benzene-1,3-diol; CHEBI:69099; NP-015156; 2-(3,4-Dihydroxyphenyl)-4,6-dimethoxy-5-prenylbenzofuran; NCGC00385808-01_C21H22O5_4-[4,6-Dimethoxy-5-(3-methyl-2-buten-1-yl)-1-benzofuran-2-yl]-1,3-benzenediol; AC1LA3EP; 4-[4,6-dimethoxy-5-(3-methylbut-2-en-1-yl)-1-benzofuran-2-yl]benzene-1,3-diol; CTK4B5314; AKOS032949097; LMPK12160046; 4-[4,6-dimethoxy-5-(3-methylbut-2-enyl)benzofuran-2-yl]resorcinol; 4-[4,6-dimethoxy-5-(3-methylbut-2-enyl)-2-benzofuranyl]benzene-1,3-diol; 4-[4,6-Dimethoxy-5-(3-methyl-2-butenyl)-2-benzofuranyl]-1,3-benzenediol, 9CI; 4-[4,6-Dimethoxy-5-(3-methyl-but-2-enyl)-benzofuran-2-yl]-benzene-1,3-diol; AIDS095916 | 354.4 | ||
| TCMBANKIN038969 | alpha-Trihydroxy coprostanic acid | 2-methyl-6-[(5S,10S)-3,7,12-trihydroxy-10-methyl-1,2,3,4,5,6,7,8,9,11,12,13,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]heptanoic acid; AC1NT156 | C26H44O5 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@]([H])(O[H])[C@]([H])([C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C(=O)O[H])C([H]) ([H])C2([H])[H])[C@]23[H])[C@@]3([H])[C@@]([H])(O[H])C4([H])[H])[C@@]4([H])C([H])([H])[C@]1([H])O[H] | |
| TCMBANKIN039049 | Isoviolanthin | 7,4'-Dihydroxyflavone; isoviolanthin | 254.24 | ||
| TCMBANKIN039051 | Glyzaglabrin | 7,2'-Dihydroxy-3',4'-methylenedioxyisoflavone; AC1NSW1C; LMPK12050085; 7-hydroxy-3-(4-hydroxy-1,3-benzodioxol-5-yl)chromen-4-one; 7-hydroxy-3-(4-hydroxy-1,3-benzodioxol-5-yl)-4-chromenone; 7-hydroxy-3-(4-hydroxy-1,3-benzodioxol-5-yl)chromone; glyzaglabrin | C16H10O6 | 298.25 g/mol | C1OC2=C(O1)C(=C(C=C2)C3=COC4=C(C3=O)C=CC(=C4)O)O |
| TCMBANKIN039734 | licoricesaponin d3 | C50H76O21 | 1013.1 g/mol | CC1C(C(C(C(O1)OC2C(C(OC(C2O)OC3C(C(C(OC3OC4CCC5(C(C4(C)C)CCC6(C5CC=C7C6(CCC8(C7CC(CC8OC(=O)C)(C)C(=O)O)C)C)C)C)C(=O)O)O)O)C(=O)O)O)O)O)O | |
| TCMBANKIN039832 | Phaseol | 336.3 g/mol | |||
| TCMBANKIN039936 | schaftoside | 6-C-beta-glucopyranosyl-8-C-alpha-arabinopyranosylapigenin; schaftoside | C26H28O14 | 564 | c12c(OC(c3c([H])c([H])c(O[H])c([H])c3[H])=C([H])C1=O)c([C@]4([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O4)c(O[H])c([C@]5([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H]) (C([H])([H])O[H])O5)c2O[H] |
| TCMBANKIN040273 | Licocoumarone | ZINC3648307; SCHEMBL758659; licocoumarone; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)benzofuran-2-yl]benzene-1,3-diol; BDBM50325939; AIDS-166092; AC1L9XR8; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)-1-benzofuran-2-yl]benzene-1,3-diol; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)-2-benzofuranyl]benzene-1,3-diol; CHEMBL611368; AIDS166092; 4-[6-Hydroxy-4-methoxy-5-(3-methyl-but-2-enyl)-benzofuran-2-yl]-benzene-1,3-diol; 2-(2',4'-dihydroxyphenyl)-6-hydroxy-5-isopentenyl-4-methoxybenzofuran; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)benzofuran-2-yl]resorcinol; LMPK12160045; 4-[6-Hydroxy-4-methoxy-5-(3-methyl-2-butenyl)-2-benzofuranyl]-1,3-benzenediol, 9CI; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)-1-benzofuran-2-yl]benzene-1,3-diol; CHEBI:69098; 2-(3,4-Dihydroxyphenyl)-6-hydroxy-4-methoxy-5-prenylbenzofuran | C20H20O5 | 340.37 | CC(=CCC1=C(C2=C(C=C1O)OC(=C2)C3=C(C=C(C=C3)O)O)OC)C |
| TCMBANKIN040366 | Licoflavonol | licoflavonol; 3,5,7-Trihydroxy-2-(4-hydroxy-phenyl)-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chromone; AIDS-095974; AIDS095974; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chromen-4-one; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-chromenone; 60197-60-6 | C20H18O6 | 354.35 | CC(=CCC1=C(C2=C(C=C1O)OC(=C(C2=O)O)C3=CC=C(C=C3)O)O)C |
| TCMBANKIN040550 | Glyasperin C | 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chroman-3-yl]benzene-1,3-diol; AIDS-096014; 4-[(R)-7-Hydroxy-5-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl]-benzene-1,3-diol; 4-((R)-7-Hydroxy-5-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl)-benzene-1,3-diol; 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)-3-chromanyl]benzene-1,3-diol; AIDS096014; 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chroman-3-yl]resorcinol; 142474-53-1; glyasperin c | C21H24O5 | 356.41 | CC(=CCC1=C(C2=C(C=C1O)OCC(C2)C3=C(C=C(C=C3)O)O)OC)C |
| TCMBANKIN040705 | Licoisoflavone B | 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethyl-6-chromenyl)-4-chromenone; 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethyl-chromen-6-yl)chromone; 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethylchromen-6-yl)chromen-4-one; 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethyl-chromen-6-yl)chromen-4-one; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl; AIDS071701; 66056-30-2; AIDS-071701 | 352.34 | ||
| TCMBANKIN040788 | liquiritin | (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxyphenyl]chroman-4-one; CTK8G0592; 7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one; MCULE-9356107980; 4H-1-Benzopyran-4-one, 2-(4-(beta-D-glucopyranosyloxy)phenyl)-2,3-dihydro-7-hydroxy-, (S)-; 7-Hydroxyflavanone 4'-O-glucoside; (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]chroman-4-one; (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chroman-4-one; MLS000575018; AIDS166098; 4',7-Dihydroxyflavanone 4'-(beta-D-glucopyranoside); 551-15-5; SMR000232362; AIDS-166098; Likviritin; 4',7-Dihydroxyflavanone 4'-(beta-D-glucoside); 100483-53-2; MolPort-021-804-452; 17654-21-6; Liquiritoside; 30372-08-8; (S)-7-Hydroxy-2-[4-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-phenyl]-chroman-4-one; 31564-20-2; (2S)-7-hydroxy-2-[4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]-4-chromanone; (S)-2-(4-(beta-D-Glucopyranosyloxy)phenyl)-2,3-dihydro-7-hydroxy-4H-1-benzopyran-4-one; LMPK12140021 | C21H22O9 | 418.394 | c1([H])c([H])c(C(=O)C([H])([H])[C@]([H])(c2c([H])c([H])c(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])c([H])c2[H])O4)c4c([H])c1O[H] |
| TCMBANKIN040793 | Dibutyl uralsaponin A ester | ||||
| TCMBANKIN040896 | Violanthin | 578.52 | |||
| TCMBANKIN041280 | Licochalcone B | licochalcone b; AIDS095932; 3-(3,4-dihydroxy-2-methoxy-phenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; 58749-23-8; (E)-3-(3,4-dihydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-3-(3,4-Dihydroxy-2-methoxy-phenyl)-1-(4-hydroxy-phenyl)propenone; (E)-3-(3,4-dihydroxy-2-methoxy-phenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-3-(3,4-Dihydroxy-2-methoxy-phenyl)-1-(4-hydroxy-phenyl)-propenone; 3-(3,4-dihydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; AIDS-095932 | 286.279 | ||
| TCMBANKIN042169 | licofuranocoumarin | 6-(2,4-dihydroxyphenyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofuro[3,2-g]chromen-7-one; 12N25RCC2E; Licofuranocoumarin; UNII-12N25RCC2E; 329319-07-5; AC1NSXJQ; 3-(2,4-dihydroxyphenyl)-7-(2-hydroxypropan-2-yl)-5-methoxy-2H,6H,7H-furo[3,2-g]chromen-2-one; 2,4'-Dihydroxy-5-methoxy-5''-(1-hydroxy-1-methylethyl)-4'',5''-dihydrofurano[2'',3'':7,6]-3-phenylcoumarin; 7H-Furo(3,2-g)(1)benzopyran-7-one, 6-(2,4-dihydroxyphenyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-, (-)- | C21H20O7 | 384.379 | C1(=O)Oc(c([H])c2c(C([H])([H])[C@]([H])(C(O[H])(C([H])([H])[H])C([H])([H])[H])O2)c3OC([H])([H])[H])c3C([H])=C1c4c([H])c([H])c(O[H])c([H])c4O[H] |
| TCMBANKIN042672 | Gancaonin F | LMPK12090043; Gancaonin F | C21H16O6 | 364.348 | C1(C([H])([H])[H])(C([H])([H])[H])Oc(c([H])c(OC(=O)c(c2c(c([H])c(O[H])c([H])c2[H])o3)c34)c4c5OC([H])([H])[H])c5C([H])=C1[H] |
| TCMBANKIN042718 | Gancaonin P | 129145-54-6; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-(3-methylbut-2-enyl)-4-chromenone; AIDS-095976; gancaonin p; AIDS095976; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-(3-methylbut-2-enyl)chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-(3-methylbut-2-enyl)chromone; 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one | C20H18O7 | 370.35 | CC(=CCC1=C(C2=C(C=C1O)OC(=C(C2=O)O)C3=CC(=C(C=C3)O)O)O)C |
| TCMBANKIN042768 | Neoisoliquiritin | LMPK12120022 | 418.4 g/mol | ||
| TCMBANKIN043133 | Echinatin | 270.28 | |||
| TCMBANKIN043167 | gancaonin x | C21H22O4 | 338.4 g/mol | CC1(C=CC2=C(O1)C=C3C(=C2)CC(CO3)C4=C(C=C(C=C4)OC)O)C | |
| TCMBANKIN043291 | licoricesaponine d3 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(C(OC3OC4CC(C5CCC6(C(C5(C4)C)C=CC7C6(CCC8(C7CC(CC8OC(=O)C)(C)C(=O)O)C)C)C)(C)C)C(=O)O)O)O)C(=O)O)O)O)O)O)O | |||
| TCMBANKIN043381 | Licobichalcone | 570.5 g/mol | |||
| TCMBANKIN043419 | glyasperin E | glyasperin e | 444.51 | CC(=CCC1=C(C=C2C(=C1O)C(=O)C(=CO2)OC3=C(C=C(C=C3)O)O)OC)C | |
| TCMBANKIN043447 | 8-Prenylated eriodictyol | 356.4 | |||
| TCMBANKIN043458 | Isotrifoliol | 529JR7020Z; 3,9-dihydroxy-1-methoxy-benzofurano[3,2-c]chromen-6-one; 3,9-Dihydroxy-1-methoxycoumestan; 3,9-dihydroxy-1-methoxy-[1]benzofuro[3,2-c]chromen-6-one; 3,9-dihydroxy-1-methoxy-[1]benzoxolo[3,2-c]chromen-6-one; 329319-08-6; UNII-529JR7020Z; 6H-Benzofuro(3,2-C)(1)benzopyran-6-one, 3,9-dihydroxy-1-methoxy-; AC1NSX6I; 3,9-dihydroxy-1-methoxy-6-benzofurano[3,2-c]chromenone; 3,9-dihydroxy-1-methoxy-6H-benzofuro[3,2-c]chromen-6-one; 5,14-dihydroxy-3-methoxy-8,17-dioxatetracyclo[8.7.0.0;{2,7}.0;{11,16}]heptadeca-1(10),2,4,6,11,13,15-heptaen-9-one; SCHEMBL15383648; isotrifoliol | C16H10O6 | 298.25 g/mol | COC1=CC(=CC2=C1C3=C(C4=C(O3)C=C(C=C4)O)C(=O)O2)O |
| TCMBANKIN043601 | Isoglabrolide | 468.67 | |||
| TCMBANKIN043795 | Gancaonin A | 5,7-Dihydroxy-4'-methoxy-6-prenylisoflavone; LMPK12050225; SCHEMBL572123; AC1NSVNM; 27762-99-8; 5,7-dihydroxy-3-(4-methoxyphenyl)-6-(3-methylbut-2-enyl)chromen-4-one; 5,7-dihydroxy-3-(4-methoxyphenyl)-6-(3-methylbut-2-enyl)chromone; gancaonin a; 5,7-dihydroxy-3-(4-methoxyphenyl)-6-(3-methylbut-2-enyl)-4-chromenone | C21H20O5 | 352.38 | CC(=CCC1=C(C2=C(C=C1O)OC=C(C2=O)C3=CC=C(C=C3)OC)O)C |
| TCMBANKIN043884 | Licoisoflavone | 66056-19-7; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-chromen-4-one; 3-[2,4-Dihydroxy-3-(3-methyl-but-2-enyl)-phenyl]-5,7-dihydroxy-1-benzopyran-4-one; licoisoflavone; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxychromen-4-one; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-4-chromenone; Licoisoflavone A; AIDS071699; 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-chromone; C10486; AIDS-071699 | C20H18O6 | 354.35 | CC(=CCC1=C(C=CC(=C1O)C2=COC3=CC(=CC(=C3C2=O)O)O)O)C |
| TCMBANKIN043948 | Licoricesaponin A3 | 985.1 g/mol | |||
| TCMBANKIN044084 | 18alpha-glycyrrhetinic acid | J-008025; A-GLYCYRRHETINIC ACID; 1449-05-4; 18-; CG0020; 18 alpha-glycyrrhetinic acid; SMP1_000143 | C30H46O4 | 470.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN044136 | Kanzonol L | 488.6 g/mol | |||
| TCMBANKIN044260 | 6-prenylated eriodictyol | 356.4 | |||
| TCMBANKIN044306 | 2,4,4'-trihydroxychalcone | (E)-3-(2,4-Dihydroxyphenyl)-1-(4-hydroxyphenyl)-2-propen-1-one; ZINC5037499; BDBM50027484; 2,4,4'-Trihydroxy-trans-chalcone; SCHEMBL1695380; (E)-3-(2,4-dihydroxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-2,4,4'-Trihydroxychalcone; CHEMBL3335591; AC1NT153; 163121-02-6; (2E)-3-(2,4-dihydroxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one | C15H12O4 | 256.253 | C([H])(=C([H])/c1c([H])c([H])c(O[H])c([H])c1[H])/C(c2c(O[H])c([H])c(O[H])c([H])c2[H])=O |
| TCMBANKIN044408 | Licoagroisoflavone | 4-Hydroxy-6-(4-hydroxy-phenyl)-2-isopropenyl-2,3-dihydro-furo[3,2-g]chromen-5-one; 4-hydroxy-6-(4-hydroxyphenyl)-2-isopropenyl-2,3-dihydro-5H-furo[3,2-g]chromen-5-one; (2R)-4-hydroxy-6-(4-hydroxyphenyl)-2-isopropenyl-2,3-dihydrofuro[3,2-g]chromen-5-one; licoagroisoflavone; (2R)-4-hydroxy-6-(4-hydroxyphenyl)-2-prop-1-en-2-yl-2,3-dihydrofuro[3,2-g]chromen-5-one; 5H-furo[3,2-g][1]benzopyran-5-one, 2,3-dihydro-4-hydroxy-6-(4-hydroxyphenyl)-2-(1-methylethenyl)-, (2R)-; 5''-(S)-5,4'-Dihydroxy-5''-isopropenyl-4'',5''-dihydrofurano[2'',3'':6,7]isoflavone; InChI=1/C20H16O5/c1-10(2)15-7-13-16(25-15)8-17-18(19(13)22)20(23)14(9-24-17)11-3-5-12(21)6-4-11/h3-6,8-9,15,21-22H,1,7H2,2H3/t15-/m1/s | 336.3 g/mol | ||
| TCMBANKIN044518 | Isograbrol | 392.53 | |||
| TCMBANKIN044686 | Isoglycyrol | 1H,7H-Benzofuro(3,2-c)pyrano(3,2-g)(1)benzopyran-7-one, 2,3-dihydro-10-hydroxy-13-methoxy-3,3-dimethyl-; AIDS095930; AIDS-095930; LMPK12090045; 23013-86-7; isoglycyrol; 10-Hydroxy-13-methoxy-3,3-dimethyl-2,3-dihydro-1H-benzofuro[3,2-c]pyrano[3,2-g][1]benzopyran-7-one | C21H18O6 | 366.36 | CC1(CCC2=C(O1)C=C3C(=C2OC)C4=C(C5=C(O4)C=C(C=C5)O)C(=O)O3)C |
| TCMBANKIN044756 | 6,8-bis(c-glucosyl)-apigenin | C27H30O15 | C1=CC(=CC=C1C2=C(C(=O)C3=C(C(=C(C=C3O2)O)C4C(C(C(C(O4)CO)O)O)O)O)C5C(C(C(C(O5)CO)O)O)O)O | ||
| TCMBANKIN044810 | Liquiritin apioside | liquiritin apioside | C26H30O13 | 551 | [C@]1([H])(c2c([H])c([H])c(O[C@@]3([H])[C@]([H])(O[C@]4([H])[C@@]([H])(O[H])[C@](O[H])(C([H])([H])O[H])C([H])([H])O4)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O3)c([H])c2[H])Oc(c([H])c (O[H])c([H])c5[H])c5C(=O)C1([H])[H] |
| TCMBANKIN045149 | Gancaonin D | 5,7-dihydroxy-3-(3-hydroxy-4-methoxyphenyl)-8-[(E)-4-hydroxy-3-methylbut-2-enyl]chromen-4-one; 5,7-dihydroxy-3-(3-hydroxy-4-methoxy-phenyl)-8-[(E)-4-hydroxy-3-methyl-but-2-enyl]chromone; 5,7-dihydroxy-3-(3-hydroxy-4-methoxy-phenyl)-8-[(E)-4-hydroxy-3-methyl-but-2-enyl]chromen-4-one; 5,7-dihydroxy-3-(3-hydroxy-4-methoxyphenyl)-8-[(E)-4-hydroxy-3-methylbut-2-enyl]-4-chromenone; AC1NSVNV; 3',5,7-Trihydroxy-4'-methoxy-8-(4-hydroxyprenyl)isoflavone; gancaonin d; LMPK12050263 | C21H20O7 | 384.379 | c1(O[H])c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])O[H])c(OC([H])=C(c2c([H])c(O[H])c(OC([H])([H])[H])c([H])c2[H])C3=O)c3c(O[H])c1[H] |
| TCMBANKIN045403 | Araboglycyrrhizin | araboglycyrrhizin | 778.92 | ||
| TCMBANKIN045476 | vicenin-2 | 5,7,4'-Trihydroxyflavone-6,8-di-C-glucoside; MLS000575019; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; Apigenin-6,8-di-C-glycoside; SMR000232371; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; C10195; vicenin- 2; 23666-13-9; vicenin-2; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one | C27H30O15 | 595 | c1([C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c(O[H])c(C(=O)C([H])=C(c3c([H])c([H])c(O[H])c([H])c3[H])O4)c4c([C@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[ H])[C@]([H])(O[H])[C@@]5([H])O[H])c1O[H] |
| TCMBANKIN045990 | Lupiwighteone | lupiwighteone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-4-chromenone; 8-prenyl-5,7,4'-trihydroxyisoflavone; 5,7,4'-Trihydroxy-8-(3,3-dimethylallyl)isoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chromone; MEGxp0_000421; 5,7-dihydroxy-3-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one | C20H18O5 | 338.35 | CC(=CCC1=C(C=C(C2=C1OC=C(C2=O)C3=CC=C(C=C3)O)O)[O-])C |
| TCMBANKIN046128 | glabrolide | C30H44O4 | 468.67 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C)C)C | |
| TCMBANKIN046142 | Licoleafol | LMPK12140410; (2S)-5,7,3',4'-Tetrahydroxy-8-[(E)-3-hydroxymethyl-2-butenyl]flavanone; Licoleafol | 372.4 g/mol | ||
| TCMBANKIN046148 | glabrene | 8-(7-hydroxy-2H-chromen-3-yl)-2,2-dimethylchromen-5-ol; 8-(7-hydroxy-2H-chromen-3-yl)-2,2-dimethyl-chromen-5-ol; 2',2'-Dimethyl-2H,2'H-(3,8')bi(1-benzopyranyl)-7,5'-diol; glabrene; 8-(7-hydroxy-2H-chromen-3-yl)-2,2-dimethyl-5-chromenol; 2',2'-Dimethyl-2H,2'H-[3,8']bi[1-benzopyranyl]-7,5'-diol; AIDS095911; AIDS-095911; 60008-03-9 | C20H20O4 | 324.37 | c1(O[H])c([H])c(OC([H])([H])C(c2c([H])c([H])c(OC(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C3([H])[H])c3c2O[H])=C4[H])c4c([H])c1[H] |
| TCMBANKIN046295 | Xambioona | 388.5 g/mol | |||
| TCMBANKIN046356 | Inflacoumarin A | 7-hydroxy-4-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-2-chromenone; inflacoumarin a; 7-hydroxy-4-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)coumarin; 7-hydroxy-4-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chromen-2-one | 322.35 | ||
| TCMBANKIN046408 | isoorientin | isoorientin 7-olate; isoorientin(1-); Isoorientin; AIDS-026707; 2-(3,4-Dihydroxyphenyl)-6-beta-D-glucopyranosyl-5,7-dihydroxy-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-beta-D-glucopyranosyl-5,7-dihydroxy-; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; C01821; NCGC00163566-01; (1S)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-oxido-4-oxo-4H-chromen-6-yl]-D-glucitol; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; 4261-42-1; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; AIDS026707; CHEBI:58333; CHEBI:17965; (1S)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-6-yl]-D-glucitol; 6C-hexosyl luteolin; Homoorientin; isoorientin anion; isoorientin ; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; Luteolin 6-C-glucoside | C21H20O11 | 448.377 | c12c(OC(c3c([H])c([H])c(O[H])c(O[H])c3[H])=C([H])C1=O)c([H])c(O[H])c([C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O4)c2O[H] |
| TCMBANKIN046419 | 7-Methoxy-2-methyl isoflavone | 7-methoxy-2-methyl-3-phenylchromen-4-one; MLS001048849; Oprea1_185553; 7-methoxy-2-methyl-3-phenyl-chromone; ZINC00520945; 7-Methoxy-2-methyl-3-phenyl-4H-chromen-4-one; MLS000556973; AIDS-130588; 7-methoxy-2-methyl isoflavone; 7-Methoxy-2-methyl-3-phenyl-chromen-4-one; SMR000148090; ST5071001; Oprea1_144261; AIDS130588; 7-methoxy-2-methyl-3-phenyl-4-chromenone; NSC605906 | 266.29 | ||
| TCMBANKIN046490 | Hispaglabridin A | AIDS096018; 4-((R)-8,8-Dimethyl-3,4-dihydro-2H,8H-benzo[1,2-b:4,3-b']dipyran-3-yl)-2-(3-methyl-but-2-enyl)-benzene-1,3-diol; 4-(8,8-dimethyl-3,4,9,10-tetrahydro-2H-pyrano[2,3-h]chromen-3-yl)-2-(3-methylbut-2-enyl)benzene-1,3-diol; C10425; 68978-03-0; 4-((R)-8,8-Dimethyl-3,4-dihydro-2H,8H-benzo(1,2-b:4,3-b')dipyran-3-yl)-2-(3-methyl-but-2-enyl)-benzene-1,3-diol; 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]-2-(3-methylbut-2-enyl)benzene-1,3-diol; AIDS-096018; 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]-2-(3-methylbut-2-enyl)resorcinol; hispaglabridin a; AC1NSWBM | C25H28O4 | 392.49 | CC(=CCC1=C(C=CC(=C1O)C2CC3=C(C4=C(C=C3)OC(C=C4)(C)C)OC2)O)C |
| TCMBANKIN046562 | Glyurallin A | 352.4 g/mol | |||
| TCMBANKIN046685 | Methyl 18α-hydroxyglycyrrhetate | methyl 18alpha-hydroxyglycyrrhetate | |||
| TCMBANKIN046782 | Glycyphyllin | LMPK12120516 | 420.4 g/mol | ||
| TCMBANKIN047042 | Glyasperin A | 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromen-4-one; 3,5,7-Trihydroxy-2-(4-hydroxy-3-(3-methyl-but-2-enyl)-phenyl)-6-((Z)-3-methyl-but-2-enyl)-1-benzopyran-4-one; AIDS095973; 3,5,7-Trihydroxy-2-[4-hydroxy-3-(3-methyl-but-2-enyl)-phenyl]-6-((Z)-3-methyl-but-2-enyl)-1-benzopyran-4-one; 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)-4-chromenone; AIDS-095973; 142474-52-0; 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromone; glyasperin a | 422.47 | ||
| TCMBANKIN047119 | Isoglycycoumarin | 368.38 | |||
| TCMBANKIN047181 | Isoliensinine | 7-Isoquinolinol, 1,2,3,4-tetrahydro-1-((4-hydroxy-3-((1,2,3,4-tetrahydro-6-methoxy-1-((4-methoxyphenyl)methyl)-2-methyl-7-isoquinolinyl)oxy)phenyl)methyl)-6-methoxy-2-methyl-, (R-(R*,R*))-; 1-{[4-hydroxy-3-({6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenyl]methyl}-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; (1R)-1-[4-hydroxy-3-[[(1R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]benzyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; Isoliensinine; Isoliensinin; 6817-41-0; (1R)-1-[[4-hydroxy-3-[[(1R)-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; 7-Isoquinolinol, 1,2,3,4-tetrahydro-1-[[4-hydroxy-3-[[(1R)-1,2,3,4-tetrahydro-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-7-isoquinolinyl]oxy]phenyl]methyl]-6-methoxy-2-methyl-, (1R)-; AIDS-226951; AIDS226951 | C39H45NO6 | 624 | c1(OC([H])([H])[H])c([H])c(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@]2(C([H])([H])[H])C([H])([H])c3c([H])c([H])c(OC([H])([H])[H])c([H])c3[H])c2c([H])c1Oc4c(O[H])c([H])c([H])c(C([H])([H])[C@] 5([H])c(c([H])c(O[H])c(OC([H])([H])[H])c6[H])c6C([H])([H])C([H])([H])N5C([H])([H])[H])c4[H] |
| TCMBANKIN047200 | apioglycyrrhizin | C41H62O14 | 778.92 | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(CO5)(CO)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN047231 | Semilicoisoflavone B | 5,7,8'-Trihydroxy-2',2'-dimethyl-2'H-(3,6')bi(1-benzopyranyl)-4-one; 5,7,8'-Trihydroxy-2',2'-dimethyl-2'H-[3,6']bi[1-benzopyranyl]-4-one; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-chromen-6-yl)chromone; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-chromen-6-yl)chromen-4-one; AIDS095919; AIDS-095919; 129280-33-7; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethylchromen-6-yl)chromen-4-one; semilicoisoflavone b; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-6-chromenyl)-4-chromenone | 352.34 | ||
| TCMBANKIN047243 | glyasperin F | glyasperin f | C20H18O6 | 354.4 g/mol | CC1(C=CC2=C(C=CC(=C2O1)C3COC4=CC(=CC(=C4C3=O)O)O)O)C |
| TCMBANKIN047319 | Glyarallin B | ||||
| TCMBANKIN047682 | Gancaonin G | 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-6-(3-methylbut-2-enyl)-4-chromenone; AIDS095920; 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-6-(3-methylbut-2-enyl)chromen-4-one; 126716-34-5; 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-6-(3-methylbut-2-enyl)chromone; gancaonin g; AIDS-095920; 5-Hydroxy-3-(4-hydroxy-phenyl)-7-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one | C21H20O5 | 352.38 | CC(=CCC1=C(C=C2C(=C1O)C(=O)C(=CO2)C3=CC=C(C=C3)O)OC)C |
| TCMBANKIN047760 | gancaonin e | AC1LA3E4; CTK4B4006; (S)-3',4',5,7-Tetrahydroxy-5',8-diprenylflavanone; SCHEMBL1170822; Gancaonin E; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-enyl)chroman-4-one; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one; LMPK12140402; 2-[3,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-4h-chromen-4-one; 2-(3,4-Dihydroxy-5-((E)-3-methyl-but-2-enyl)-phenyl)-5,7-dihydroxy-8-(3-methyl-but-2-enyl)-1-benzopyran-4-one; 124596-89-0; ACMC-20bulj; AC1Q6KJ0; 4',5,5',7-Tetrahydroxy-3',8-bis(3-methyl-2-butenyl)flavanone; 2-[3,4-Dihydroxy-5-((E)-3-methyl-but-2-enyl)-phenyl]-5,7-dihydroxy-8-(3-methyl-but-2-enyl)-1-benzopyran-4-one | C25H28O6 | 424.5 g/mol | CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(C=C(C(=C3O2)CC=C(C)C)O)O)O)O)C |
| TCMBANKIN047857 | Glyasperin B | glyasperin b | 370.4 | ||
| TCMBANKIN047935 | Kanzonol Z | kanzonolz | 406.47 | ||
| TCMBANKIN048103 | Licorisoflavan A | CHEMBL598721 | 438.6 g/mol | ||
| TCMBANKIN048258 | licoricesaponine c2 | AC1O3DKK; (2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6S)-2-[[(2R,6aR,8aS,11S,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-2-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | CC1(CC(CC2(C1CCC3(C2C=CC4=C5CC(CCC5(CCC43C)C)(C)C(=O)O)C)C)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)C(=O)O)O)O)O)C | ||
| TCMBANKIN048382 | licuraside | C26H30O13 | 551 | C(c1c([H])c([H])c(O[H])c([H])c1O[H])(=O)\C([H])=C([H])\c2c([H])c([H])c(O[C@]3([H])[C@@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@@](O[H])(C([H])([H])O[H])C([H])([H])O4)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H ])(C([H])([H])O[H])O3)c([H])c2[H] | |
| TCMBANKIN048624 | licoricesaponin e2 | C42H60O16 | 820.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC8(CC7OC8=O)C)C)C)C)C | |
| TCMBANKIN048729 | Gancaonin B | gancaonin b; DTXSID60154437; 5,7,3'-Trihydroxy-4'-methoxy-6-prenylisoflavone; 124596-86-7; 5,7-dihydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-(3-methylbut-2-enyl)chromone; AIDS-095921; SCHEMBL1170939; LMPK12050262; AIDS095921; 5,7-dihydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-(3-methylbut-2-enyl)chromen-4-one; AK583693; 4H-1-Benzopyran-4-one,5,7-dihydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-(3-methyl-2-buten-1-yl)-; 5,7-Dihydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-(3-methylbut-2-en-1-yl)-4H-chromen-4-one; 3',5,7-Trihydroxy-4'-methoxy-6-prenylisoflavone; CTK4B4004; 5,7-Dihydroxy-3-(3-hydroxy-4-methoxy-phenyl)-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one; AKOS030553634; 5,7-dihydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-(3-methylbut-2-enyl)chromen-4-one; 5,7-dihydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-(3-methylbut-2-enyl)-4-chromenone; ACMC-20mr47; AC1NSVNP | C21H20O6 | 368.38 | CC(=CCC1=C(C2=C(C=C1O)OC=C(C2=O)C3=CC(=C(C=C3)OC)O)O)C |
| TCMBANKIN048791 | licochalcone A | AIDS-060352; D08GEN; LMPK12120424; 749L227; AN-276; (E)-3-[5-(1,1-Dimethyl-allyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxy-phenyl)-propenone; (2E)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-3-[5-(1,1-dimethylallyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; Licochalcone-A, Synthetic; LICOAGROCHACONE A; SCHEMBL114042; HY-N0372; licochalcone a; CS-5603; 4 inverted exclamation marka,4-Dihydroxy-3-; EX-A1193; BRD-K99667445-001-01-4; 2-Propen-1-one, 3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)- (E)-; Licohalconel A; AIDS060352; 3-[5-((E)-1,1-Dimethyl-allyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxy-phenyl)-propenone; (E)-3-(4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one; 3-[5-(1,1-dimethylprop-2-enyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; (E)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; (2E)-3-[5-(1,1-dimethylprop-2-en-1-yl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; NP-012615; Q-100677; AK198741; 3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; 3-[5-(1,1-dimethylprop-2-enyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; C21H22O4; 3-Dimethylallyl-4,4'-dihydroxy-6-methoxychalcone; s7828; KAZSKMJFUPEHHW-DHZHZOJOSA-N; (E)-3-[5-(1,1-dimethylprop-2-enyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; BDBM50068270; LS-122598; HSCI1_000078; MolPort-005-945-554; JTV5467968; ZINC3873123; Licochalcone-A; MolPort-044-567-637; (E)-3-[5-(1,1-dimethylprop-2-enyl)-4-hydroxy-2-methoxy-phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one; V2343; Licochalcone A; 58749-22-7; CCG-208030; Licochalcone A, >=96.0% (HPLC); AB0021119; EBD46703; CHEMBL139702; CHEBI:125689; UNII-JTV5467968; AC1NSXJH; AKOS026673964; A-dimethylallyl-6-methoxychalcone; 2-Propen-1-one, 3-(5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-, (E)-; (E)-3-[5-(1,1-Dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxyphenyl)-2-propen-1-one; BG01626652 | C21H22O4 | 338.397 | c1(O[H])c([H])c([H])c(C(=O)\C([H])=C([H])/c2c([H])c(C(C([H])=C([H])[H])(C([H])([H])[H])C([H])([H])[H])c(O[H])c([H])c2OC([H])([H])[H])c([H])c1[H] |
| TCMBANKIN049097 | Licoagropin | 320.46 | |||
| TCMBANKIN049133 | Kanzonol K | 436.5 g/mol | |||
| TCMBANKIN049471 | glabrol | C25H28O4 | 392.487 | [C@]1([H])(c2c([H])c([H])c(O[H])c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])c2[H])Oc(c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])c(O[H])c([H])c3[H])c3C(=O)C1([H])[H] | |
| TCMBANKIN049856 | uralstilbene | C24H30O4 | 382.5 g/mol | CC(=CCC1=C(C=C(C=C1OCC=C(C)C)O)CCC2=CC(=C(C=C2)O)O)C | |
| TCMBANKIN049863 | licochalcone C | licochalcone c | C21H22O4 | 338.4 | CC(=CCC1=C(C=CC(=C1OC)C=CC(=O)C2=CC=C(C=C2)O)O)C |
| TCMBANKIN050237 | licopyranocoumarin | AC1L3VDZ; GU 7; 3-(3,4-Dihydroxyphenyl)-8-hydroxymethyl-8-methyl-5-methoxy-6,7-dihydro-2H,8H-benzo(1,2-b-5,4-b')dipyran-2-one; 2H,6H-Benzo(1,2-b:5,4-b')dipyran-2-one, 3-(2,4-dihydroxyphenyl)-7,8-dihydro-8-(hydroxymethyl)-5-methoxy-8-methyl-; 121249-16-9; 2H,6H-Benzo(1,2-b:5,4-b')dipyran-2-one, 3-(2,4-dihydroxyphenyl)-7,8-dihydro-8-(hydroxymethyl)-5-methoxy-8-methyl-, (+)-; CHEMBL597425; 4X8VZO798F; 7-(2,4-dihydroxyphenyl)-2-(hydroxymethyl)-5-methoxy-2-methyl-3,4-dihydropyrano[3,2-g]chromen-8-one; UNII-4X8VZO798F; GU-7; SCHEMBL2221932; LMPK12160021; Licopyranocoumarin; 117038-80-9 | C21H20O7 | 384.38 | CC1(CCC2=C(O1)C=C3C(=C2OC)C=C(C(=O)O3)C4=C(C=C(C=C4)O)O)CO |
| TCMBANKIN050280 | Ethyl-n-buthy-uralsaponin A esters | ||||
| TCMBANKIN055740 | 3',4'-Dihydroxyacetophenone | C16225; 35878-41-2; (3R)-3-(2-hydroxy-4-methoxyphenyl)-7-chromanol; (3R)-3-(2-hydroxy-4-methoxyphenyl)chroman-7-ol; (3R)-3-(2-hydroxy-4-methoxy-phenyl)chroman-7-ol; 7,2'-dihydroxy-4'-methoxyisoflavan; C16225; (3S)-3-(2-hydroxy-4-methoxyphenyl)chroman-7-ol; 4CN-2332; C10540; 9JHS2AVR43; vestitol; 35878-41-2; (R)-(-)-Vestitol; (3R)-3-(2-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-chromen-7-ol; ZB015172; ZINC899922; (3R)-3-(2-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol; CTK1C3580; (3S)-3-(2-hydroxy-4-methoxyphenyl)-7-chromanol; (?)-Vestitol; CHEBI:80392; (-)-Vestitol; AC1L4ALZ; UNII-Z244UVZ669 component XRVFNNUXNVWYTI-NSHDSACASA-N; CHEMBL479145; Vestitol, (-)-; UNII-9JHS2AVR43; MolPort-039-338-174; 20879-05-4; (3S)-3-(2-hydroxy-4-methoxy-phenyl)chroman-7-ol; (3R)-3-(2-hydroxy-4-methoxy-phenyl)chroman-7-ol; Vestitol | C8H8O3 | 152.147 | c1([H])c(C(=O)C([H])([H])[H])c([H])c(O[H])c(O[H])c1[H] |
| TCMBANKIN057918 | urea | 1-Benzhydryl-3-[4-(methoxy-quinolin-8-ylamino)-pentyl]-urea; 1-(3-benzylphenyl)-3-[4-[(3-methoxy-1-naphthyl)amino]pentyl]urea; UR; Mocovina [Czech]; 51457_FLUKA; Aquacare HP; Keratinamin Kowa; KBio2_003720; 51456_FLUKA; NCGC00090892-03; NCI-C02119; 174693-33-5; 51460_FLUKA; EPA Pesticide Chemical Code 085702; KBioGR_001775; 173994-65-5; Carbaderm; 173144-80-4; Alphadrate; AIDS-003652; NSC 34375; KBio1_000086; Pastaron; HSDB 163; U7129_SIGMA; Carbamimic acid; Carbonyldiamine; c0165; 299367_ALDRICH; SPBio_001263; Ureaphil; Karbamid; NCGC00090892-01; Urea ammonium nitrate solution; Pastaron soft; Carmol 40; B-I-K; Urevert; Urea-13C; Panafil; U6504_SIGMA; 51465_FLUKA; 57-13-6; Keratinamin; Spectrum4_001168; Elaqua XX; H2NC(O)NH2; U1250_SIGMA; KBio2_001152; Urepeal L; KBio3_002843; ST5214565; URE; BSPBio_003341; D00023; Urea [JAN]; AI3-01202; NCGC00090892-02; Benural 70; WLN: ZVZ; DivK1c_000086; Pastaron (TN); carmol; Urea perhydrate; Polyurea; Hyanit; NINDS_000086; Eucerin 10% Urea Lotion; InChI=1/CH4N2O/c2-1(3)4/h(H4,2,3,4; Carbamimidic acid (VAN); U4128_SIGMA; Caswell No. 902; Spectrum_000672; Pastaron 20; U4883_SIGMA; CCRIS 989; 37955-36-5; Urea (8CI,9CI); U5128_SIAL; Varioform II; Pastaron 10; U0631_SIGMA; Harnstoff; Carbamide resin; Aqua Care; ARF; CHEBI:16199; Ureophil; Pseudourea; Ureacin-40 Creme; AIDS003652; C00086; KBioSS_001152; Optigen 1200; Spectrum5_001862; SPECTRUM1500604; Carbamimidic acid; 175276-38-7; U5378_SIGMA; carbamide; Spectrum2_001192; EINECS 200-315-5; Supercel 3000; Ureacin-10 lotion; IDI1_000086; component of Artra Ashy Skin Cream; Isourea; U4884_SIGMA; Urea solution; Aquacare; UREA; KBio2_006288; Rubinol ST 010; 51459_FLUKA; NSC34375; Aqua Care HP; Spectrum3_001791; Ultra Mide; Urepearl; uree; Prespersion, 75 urea; Urea-12C; Urea (JP15/USP); Carbonyldiamide; Harnstoff [German]; 4744-36-9; Aquadrate; Urea, homopolymer; 30535-50-3; Pastaron 20 soft; Urepeal; Carbonyl diamide; 33247_RIEDEL; Ureacin-20 | CH4N2O | 60.056 g/mol; 60.06 | C(=O)(N)N |
| TCMBANKIN058192 | isoliquiritigenin | HCC; KBio2_000625; SPBio_000949; Spectrum2_000875; 961-29-5; 2-PROPEN-1-ONE, 1-(2,4-DIHYDROXYPHENYL)-3-(4-HYDROXYPHENYL)-; SPECTRUM1504200; Chalcone, 2',4,4'-trihydroxy-; CHEMBL1395334; KBio3_002631; NCGC00015556-01; SDCCGMLS-0066751.P001; ST5309279; (2E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; KBio2_003193; InChI=1/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3; (E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; CMLD3_000056; BSPBio_003411; C08650; CCRIS 7676; 2',4,4'-Trihydroxychalcone; Lopac0_000681; 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; I159_SIGMA; 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; Lopac-I-3766; CPD-3041; KBio1_001802; MEGxp0_001326; ZINC3869607; BRN 1914295; MLS000438943; SMR000112969; Acrylophenone, 2',4'-dihydroxy-3-(p-hydroxyphenyl)-; (2E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; ACon1_000047; GU 17; KBioGR_002232; DivK1c_006858; KBio2_005761; 1-08-00-00707 (Beilstein Handbook Reference); 4,2′,4′-Trihydroxychalcone; (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; NCGC00090504-01; (Z)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; EU-0100681; Spectrum3_001656; AC1O7G44; 4,2',4'-Trihydroxychalcone; EINECS 237-316-5; I3766_SIGMA; AIDS035379; AIDS-035379; 13745-20-5; Spectrum5_000612; 2-propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (2E)-; Spectrum_000145; KBioSS_000625; Isoliquiritigenin; Spectrum4_001756; 42'4'-trihydroxychalcone; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (E)-; NCGC00090504-03; SpecPlus_000762; 2',4',4-trihydroxychalcone | C15H12O4 | 256.25 g/mol | C1=CC(=CC=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O |
| TCMBANKIN058193 | neoisoliquiritigenin | neoisoliquiritin; neoisoliquirtin; LMPK12120022 | C21H22O9 | 418.4 g/mol | C1=CC(=CC=C1C=CC(=O)C2=C(C=C(C=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O |
| TCMBANKIN058213 | kaemferol;kampferol;kaempferol;campherol | TNP00039; nchembio.2007.28-comp30; Kaempherol; 5-18-05-00251 (Beilstein Handbook Reference); Prestwick2_001098; CHEBI:28499; Prestwick1_001098; CAS-520-18-3; BRN 0304401; Flavone, 3,4',5,7-tetrahydroxy-; ST030560; MEGxp0_001283; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; C.I. 75640; Swartziol; K0133_SIGMA; kaempferol oxoanion; NCGC00016480-01; 60010_FLUKA; EINECS 208-287-6; Pelargidenon; Nimbecetin; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NSC 407289; 3,4',5,7-Tetrahydroxyflavone; HSCI1_000027; Pelargidenolon 1497; NSC407289; Robigenin; C05903; CPD1F-90; Kampferol; NSC 656277; Prestwick0_001098; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Populnetin; Kampcetin; Prestwick3_001098; AIDS-001404; ZINC00137345; kaempferol ; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-olate; 3,4′,5,7-Tetrahydroxyflavone; Rhamnolutein; NCGC00016480-02; ACon1_001867; NSC656277; 3,4′,5,7-Tetrahydroxyflavone; BSPBio_001176; SPBio_003058; Oprea1_650954; 5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI); Campherol; 520-18-3; 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE; S00111; Trifolitin; Kampherol; AI3-36096; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromone; Indigo yellow; Pelargidenolon; AIDS001404; nchembio718-comp14; NCGC00091036-01; Flavone, 3,4',5,7-tetrahydroxy- (7CI,8CI); CHEBI:58573; Kaemferol; Kempferol; BPBio1_001294; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Rhamnolutin; 3,5,7-triOH-Flavone; KMP; CCRIS 41; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- | C15H10O6 | 286.24 g/mol | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN058215 | kaempferol-3-o-beta-d-glucoside | kaempferol-3-O-β-D-glucopyranoside;Kaempferol-3-glucoside;astragalin;Kaempferol-3-o- glucoside;kaempferol 3-glucoside;Kaempferol 3-O-glucoside;kaempferol-3-o-glucoside;5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside; Kaempferol-3-O-.beta.-D-glucopyranoside; Kaempferol-3-beta-glucopyranoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; NCGC00163580-01; 4H-1-Benzopyran-4-one, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-; Astragaline; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Kaempferol-3-D-glucoside; 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; MEGxp0_000168; Kaempferol-3-beta-monoglucoside; Kaempferol-3-O-glucoside; 3,4',5,7-Tetrahydroxyflavone-3-glucoside; 480-10-4; ACon1_001224; SCHEMBL23898; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; AIDS-051935; AIDS051935; CHEBI:30200; LMPK12111725; Kaempferol 3-O-beta-D-glucopyranoside; C12249; Astragalin; Kaempferol 3-O-glucoside; Kaempferol 3-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; Kaempferol 3-O-beta-D-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone;kaempferol-3-β-D-glucopyranoside;Kaempferol-3-O-β-D- glucopyranoside; kaempferol-3-o-beta-d-glucopyranoside;kaempferol-3-O-β-D-glucoside; Kaempferol-3-o-β-D- glucoside; Kaempferol- 3-O-β-D-glucoside | C21H20O11 | 448.38 | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN058240 | a,2',4,4'-tetrahydroxydihydrochalcone | 4,2',4',alpha-Tetrahydroxydihydrochalcone; (αS)-α,2',4,4'＇-tetrahydroxydihydrochalcone | C15H14O5 | 274.27 g/mol | C1=CC(=CC=C1CC(C(=O)C2=C(C=C(C=C2)O)O)O)O |
| TCMBANKIN058324 | isoflavone | genistein(1-); 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate; isoflavone ; CHEBI:74224; ST5331741; 574-12-9; 3-phenylchromen-4-one; 3-Phenylchromone; 4H-1-Benzopyran-4-one, 3-phenyl- (9CI); 3-phenyl-4H-1-benzopyran-4-one; NSC 135405; C00799; 3-phenyl-4-chromenone; CHEBI:18220; NSC135405; AIDS-002244; Isoflavone (8CI); 3-phenyl-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 3-phenyl-; Isoflavone; AIDS002244; Isoflavon | C15H10O2 | 222.24 g/mol | C1=CC=C(C=C1)C2=COC3=CC=CC=C3C2=O |
| TCMBANKIN058371 | ICO | 1H-Indole-3-carboxylic acid; EINECS 212-231-6; Indole-3-carboxylic acid; 284734_ALDRICH; 57225_FLUKA; SBB003952; CHEBI:24809; InChI=1/C9H7NO2/c11-9(12)7-5-10-8-4-2-1-3-6(7)8/h1-5,10H,(H,11,12; Oprea1_560034; SDCCGMLS-0065969.P001; 771-50-6;indole-3-carboxylic acid;indole-3-carboxylicacid;3-indolecarboxylic acid | C9H7NO2 | 161.16 g/mol | C1=CC=C2C(=C1)C(=CN2)C(=O)O |
| TCMBANKIN058479 | vicianin | Benzeneacetonitrile, alpha-((6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranosyl)oxy)-, (R)-; (2R)-2-phenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile; Vicianin; CQU61CXY3D; AC1O533C; UNII-CQU61CXY3D; lupulinoside | C19H25NO10 | 427.4 g/mol | C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C#N)C3=CC=CC=C3)O)O)O)O)O)O |
| TCMBANKIN058536 | (2S)-liquiritigenin;liquiritigenin;DFV | (2R)-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; N1793; AJ-23291; AC1LICLD; ZINC519174;4',7-Dihydroxyflavanone; 5-DEOXYFLAVANONE; 578-86-9; 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-, (S)-; 7-HYDROXY-2-(4-HYDROXY-PHENYL)-CHROMAN-4-ONE; (2S)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2S)-7-Hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one; ZINC00985403; 2885-30-5; 17002-53-8; C09762; Liquiritigenin; 7,4'-Dihydroxyflavanone; (2S)-7-hydroxy-2-(4-hydroxyphenyl)-4-chromanone; STOCK1N-11167; 16006-91-0 | C15H12O4 | 256.25 g/mol | C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O |
| TCMBANKIN058537 | liquiritigenin-7-O-D-apiosyl-4'-O-D-glucoside | Liquiritin apioside; liquiritin apioside | C26H30O13 | 550.5 g/mol | C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)OC4C(C(C(C(O4)CO)O)O)OC5C(C(CO5)(CO)O)O |
| TCMBANKIN058538 | licorice glycoside E | licorice glycoside e | C35H35NO14 | 693.6 g/mol | C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)OC4C(C(C(C(O4)CO)O)O)OC5C(C(CO5)(COC(=O)C6=CNC7=CC=CC=C76)O)O |
| TCMBANKIN058585 | norlobelanine | isolobelanine | C21H23NO2 | 321.4 g/mol | C1CC(NC(C1)CC(=O)C2=CC=CC=C2)CC(=O)C3=CC=CC=C3 |
| TCMBANKIN058767 | 8-Prenylwighteone; 6,8-diprenylgenistein | 5,7-dihydroxy-3-(4-hydroxyphenyl)-6,8-bis(3-methylbut-2-enyl)-4-chromenone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-6,8-bis(3-methylbut-2-enyl)chromen-4-one; SMR000440770; 5,7-dihydroxy-3-(4-hydroxyphenyl)-6,8-bis(3-methylbut-2-enyl)chromone; AIDS095923; MLS000863648; ACon1_000023; MEGxp0_000423; 5,7-Dihydroxy-3-(4-hydroxy-phenyl)-8-(-3-methyl-but-2-enyl)-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one; AIDS-095923 | C25H26O5 | 406.47 | CC(=CCC1=C(C(=C2C(=C1O)C(=O)C(=CO2)C3=CC=C(C=C3)O)CC=C(C)C)O)C |
| TCMBANKIN058770 | Uralenol-3-methylether | 3',4',5,7-Tetrahydroxy-3-methoxy-5'-prenylflavone; DTXSID00164631; uralenol-3-methylether; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-3-methoxy-chromen-4-one; 150853-98-8; 5,7,3',4'-Tetrahydroxy-3-methoxy-5'-isoprenylflavone; 3-O-Methyluralenol; 2-[3,4-Dihydroxy-5-(3-methyl-2-butenyl)phenyl]-5,7-dihydroxy-3-methoxy-4H-1-benzopyran-4-one; Podoverine A; AC1NSSOR; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-3-methoxy-4-chromenone; LMPK12112721; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-3-methoxychromen-4-one; 5,7,3',4'-Tetrahydroxy-3-methoxy-5'-prenylflavone; 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-3-methoxy-chromone; 2-[3,4-DIHYDROXY-5-(3-METHYLBUT-2-EN-1-YL)PHENYL]-5,7-DIHYDROXY-3-METHOXYCHROMEN-4-ONE; 3-o-methyluralenol | C21H20O7 | 384.38 | CC(=CCC1=C(C(=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC)O)O)C |
| TCMBANKIN058777 | euchrenone | (2s)-euchrenone a16 | C25H28O5 | 406.56 | CC(=CCC1=C(C=C(C2=C1OC(CC2=O)C3=CC4=C(C=C3)OC(CC4)(C)C)O)O)C |
| TCMBANKIN058782 | (E)-1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one;(e)-1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(4-hydroxy-3-[3-methyl-2-butenyl)phenyl]-2-propen-1-one | (E)-1-[2,4-Dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(4-hydroxy-3-[3-methyl-2-butenyl)phenyl]-2-propen-1-one;(e)-1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(4-hydroxy-3-[3-methyl-2-butenyl) phenyl]-2-propen-1-one | C25H28O4 | 392.5 g/mol | CC(=CCC1=C(C=CC(=C1)C=CC(=O)C2=C(C(=C(C=C2)O)CC=C(C)C)O)O)C |
| TCMBANKIN058783 | Liconeolignan | Licobenzofuran; 82209-75-4; 2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-5,6-dimethoxy-1-benzofuran-3-ol; 3-Benzofuranol, 2-(4-hydroxy-3-(3-methyl-2-butenyl)phenyl)-5,6-dimethoxy-; 2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-5,6-dimethoxy-3-benzofuranol; 2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-5,6-dimethoxy-benzofuran-3-ol;82209-75-4; 2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-5,6-dimethoxy-1-benzofuran-3-ol; 2-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-5,6-dimethoxy-1-benzofuran-3-ol; AC1L33JL; 3-Benzofuranol, 2-(4-hydroxy-3-(3-methyl-2-butenyl)phenyl)-5,6-dimethoxy-; AC1Q7B9Q; DTXSID20231632 | C21H22O5 | 354.4 | CC(=CCC1=C(C=CC(=C1)C2=C(C3=CC(=C(C=C3O2)OC)OC)O)O)C |
| TCMBANKIN058784 | 3-Hydroxyglabrol | AIDS-096008; AC1NSWIP; (3R)-3,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one; AIDS096008; (2R,3R)-3,7-Dihydroxy-2-[4-hydroxy-3-((E)-3-methyl-but-2-enyl)-phenyl]-8-(3-methyl-but-2-enyl)-1-benzopyran-4-one; (2R,3R)-3,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)-4-chromanone; 3-hydroxyglabrol; (2R,3R)-3,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)chroman-4-one; 3-hydroxyglabrol(i) | C25H28O5 | 408.49 | CC(=CCC1=C(C=CC(=C1)C2C(C(=O)C3=C(O2)C(=C(C=C3)O)CC=C(C)C)O)O)C |
| TCMBANKIN058788 | (E)-1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-(2,4-dihydroxyphenyl)prop-2-en-1-one;2,4,2',4'-tetrahydroxy-3'-prenylchalcone | C20H20O5 | 340.37 | CC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=C(C=C(C=C2)O)O)O)C | |
| TCMBANKIN058789 | Corylifolinin | Isobavachalcone; CHEMBL253467; HY-13065; 2',4',4-trihydroxy-3'-prenylchalcone; corylifolinin; MolPort-005-944-955; J-501822; 20784-50-3; 2',4,4'-Trihydroxy-3'-(3-methyl-2-butenyl)chalcone; AKOS015912636; BG01613276; (E)-1-[2,4-Dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one; Isobacachalcone; 4-Hydroxyisocordoin; LS-186058; Y0111; MFCD00902090; C08648; 784I503; 2-Propen-1-one, 1-(2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl)-3-(4-hydroxyphenyl)-; 4-Hydroxyisocordoim; CHEBI:28106; (2E)-1-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one; RL02570; AIDS046583; 1-[2,4-Dihydroxy-3-(3-methyl-but-2-enyl)-phenyl]-3-(4-hydroxy-phenyl)-propenone; NP-007513; AC1NQYAC; EBD2198163; (e)-1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)-phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one; DUWPGRAKHMEPCM-IZZDOVSWSA-N; I14-48057; BDBM50441633; 2-Propen-1-one,1-[2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl]-3-(4-hydroxyphenyl)-, (2E)-; (E)-1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one; LMPK12120039; SCHEMBL600137; Isobavachalcone, >=98% (HPCE); 1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one; AIDS-046583; 54676-49-2; ZINC3925823; W-5204; CS-0430 | C20H20O4 | 324.37 | CC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=CC=C(C=C2)O)O)C |
| TCMBANKIN058791 | 5-o-methyl licoricidin | 4-[(3R)-5,7-dimethoxy-6-(3-methylbut-2-enyl)-3-chromanyl]-2-(3-methylbut-2-enyl)benzene-1,3-diol; AIDS-096024; 129314-37-0; 5-O-Methyllicoricidin; AIDS096024; 4-[(3R)-5,7-dimethoxy-6-(3-methylbut-2-enyl)chroman-3-yl]-2-(3-methylbut-2-enyl)benzene-1,3-diol; 4-[(3R)-5,7-dimethoxy-6-(3-methylbut-2-enyl)chroman-3-yl]-2-(3-methylbut-2-enyl)resorcinol; 4-[(R)-5,7-Dimethoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl]-2-((E)-3-methyl-but-2-enyl)-benzene-1,3-diol;Licoriisoflavan A | C27H34O5 | 438.6 g/mol | CC(=CCC1=C(C=CC(=C1O)C2CC3=C(C(=C(C=C3OC2)OC)CC=C(C)C)OC)O)C |
| TCMBANKIN058797 | 3'-o-methylgancaonin p | gancaonin p-3'-methylether; 3'-O-Methylgancaonin P; 151776-21-5; AC1NSVNY; THMIF; Gancaonin P-3'-methyl ether; DTXSID10164869; Gancaonin P 3'methyl ether; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(3-methylbut-2-enyl)chromen-4-one; LMPK12112394; 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one; 3,5,7,4'-Tetrahydroxy-3'-methoxy-6-isoprenylflavone; Gancaonin P-3'-methylether; Gancaonin P 3/'methyl ether; 3,4',5,7-Tetrahydroxy-3'-methoxy-6-prenylflavone | C21H20O7 | 384.38 g/mol | CC(=CCC1=C(C2=C(C=C1O)OC(=C(C2=O)O)C3=CC(=C(C=C3)O)OC)O)C |
| TCMBANKIN058798 | Glycyrol | MLS000697623; C16968; MolPort-039-339-022; AIDS095929; Neoglycyrol; 4CN-3163; CHEMBL132695; AKOS032949068; ZINC13130921; CHEBI:80832; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)-[1]benzoxolo[3,2-c]chromen-6-one; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)-[1]benzofuro[3,2-c]chromen-6-one; AIDS-095929; HMS2270J05; 3,9-Dihydroxy-1-methoxy-2-(3-methyl-but-2-enyl)-benzofuro[3,2-c][1]benzopyran-6-one; 23013-84-5; DTXSID00177569; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)-6-benzofurano[3,2-c]chromenone; SCHEMBL758197; AC1NSZ1D; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)benzofuro[3,2-c]chromen-6-one; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)benzofurano[3,2-c]chromen-6-one; SMR000470955; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-en-1-yl)-6H-[1]benzofuro[3,2-c][1]benzopyran-6-one; 3,9-Dihydroxy-1-methoxy-2-prenylcoumestan; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-1-methoxy-2-(3-methyl-2-butenyl)-; glycyrol;neoglycyrol | C21H18O6 | 366.4 g/mol | CC(=CCC1=C(C2=C(C=C1O)OC(=O)C3=C2OC4=C3C=CC(=C4)O)OC)C |
| TCMBANKIN058806 | Glabranin | (2S)-5,7-dihydroxy-8-(3-methylbut-2-enyl)-2-phenylchroman-4-one; NCGC00017206-01; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-8-(3-methyl-2-butenyl)-2-phenyl-, (2S)-; 41983-91-9; (2S)-5,7-dihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-chroman-4-one; glabranin; TNP00074; (2S)-5,7-dihydroxy-8-(3-methylbut-2-enyl)-2-phenyl-4-chromanone; AIDS095899; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-8-(3-methyl-2-butenyl)-2-phenyl-, (S)-; (S)-2,3-Dihydro-5,7-dihydroxy-8-(3-methyl-2-butenyl)-2-phenyl-4H-1-benzopyran-4-one; AIDS-095899; TimTec1_002029; NCGC00142379-01; ZINC00113294; C09752; ST024709;glabranine | C20H20O4 | 324.37g/mol | CC(=CCC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=CC=C3)C |
| TCMBANKIN058945 | Isoramanone | ramanone isoramanone | C21H32O4 | 348.48 | CC(=O)C1CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)O)C)O |
| TCMBANKIN059188 | beta-Terpinene | 1-isopropyl-4-methylene-cyclohexene; β-terpinene; 1-isopropyl-4-methylenecyclohexene; EINECS 202-793-0; 4-methylidene-1-propan-2-ylcyclohexene; p-Mentha-1(7),3-diene; 4-methylidene-1-propan-2-yl-cyclohexene; 99-84-3; Cyclohexene, 4-methylene-1-(1-methylethyl)-; Cyclohexene,4-methylene-1-(1-methylethyl)-; belta-terinene;Cyclohexene,4-methylene-1-(1-methylethyl) | C10H16 | 136.23 | CC(C)C1=CCC(=C)CC1 |
| TCMBANKIN059272 | diisobutyl phthalate | di-isobutyl phthalate;ST5405544; diisobutyl benzene-1,2-dicarboxylate; benzene-1,2-dicarboxylic acid diisobutyl ester; Di-iso-butyl phthalate; 80130_FLUKA; Isobutyl phthalate; bis(2-methylpropyl) benzene-1,2-dicarboxylate; (C4-C13) Branched alkyl alcohols, phthalic anhydride ester; ZINC00388318; EINECS 201-553-2; NSC15316; 1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester; Diisobutyl phthalate; 152641_ALDRICH; EINECS 273-157-8; 68951-39-3; C15205; AI3-04278; Phthalic acid, diisobutyl ester; BRN 2054802; NCGC00091360-01; NSC 15316; WLN: 1Y1&1OVR BVO1Y1&1; 4-09-00-03177 (Beilstein Handbook Reference); Diisobutylester kyseliny ftalove [Czech]; Hexaplas M/1B; 1,2-Benzenedicarboxylic acid, C4-13-branched alkyl esters; AI3-04278 (USDA); Kodaflex DIBP; 68955-80-6; Hatcol DIBP; HSDB 5247; CCRIS 6193; di-l-butyl phthalate (DIBP); Di(i-butyl)phthalate; SMR000112470; MLS000516002; 84-69-5; Palatinol IC | C16H22O4- C6H4[CO2CH2CH(CH3)2]2 | 278.34 g/mol | CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C |
| TCMBANKIN059312 | ganoderic acid AP | ganoderic acid a; ganoderic acid A; ganode-8-en-ricacid a | C30H44O7 | 516.67 | CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O |
| TCMBANKIN059457 | glycyrrhiza-flavonol a | C20H18O7 | 370.4 g/mol | CC1(C(CC2=C(O1)C=CC(=C2)C3=C(C(=O)C4=C(C=C(C=C4O3)O)O)O)O)C | |
| TCMBANKIN059488 | 1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one | C20H18O4 | 322.35 | CC1(C=CC2=C(O1)C=CC(=C2O)C(=O)C=CC3=CC=C(C=C3)O)C | |
| TCMBANKIN059489 | Glabrone | C20H16O5 | 336.34g/mol | CC1(C=CC2=C(O1)C=CC(=C2O)C3=COC4=C(C3=O)C=CC(=C4)O)C | |
| TCMBANKIN059490 | licoisoflavanone | C20H18O6 | 354.35 | CC1(C=CC2=C(O1)C=CC(=C2O)C3COC4=CC(=CC(=C4C3=O)O)O)C | |
| TCMBANKIN059538 | 11-deoxyglycyrrhetic acid | C30H48O3 | 456.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN059541 | glycyrrhizin | C42H62O16 | 822.93 | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN059542 | licoricesaponin a3 | C48H72O21 | 985.1 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)OC8C(C(C(C(O8)CO)O)O)O)C)C)C)C | |
| TCMBANKIN059543 | licorice-saponin C2 | C42H62O15 | 806.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C=CC6=C7CC(CCC7(CCC63C)C)(C)C(=O)O)C)C | |
| TCMBANKIN059544 | licoricesaponin b2 | C42H64O15 | 808.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)CC=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN059591 | methyl 3-O-β-D-glucopyranosyl polygalacate | 680.97 | CC1(CCC2(C(C1)C3=CCC4C(C3(CC2O)C)(CCC5C4(CC(C(C5(C)CO)OC6C(C(C(C(O6)CO)O)O)O)O)C)C)C(=O)OC)C | ||
| TCMBANKIN059639 | Isoglycyrol | C21H18O6 | 366.36 | CC1(CCC2=C(O1)C=C3C(=C2OC)C4=C(C5=C(O4)C=C(C=C5)O)C(=O)O3)C | |
| TCMBANKIN059691 | 7-hydroxy-2-methyl isoflavone | C16H12O3 | 252.26 g/mol | CC1=C(C(=O)C2=C(O1)C=C(C=C2)O)C3=CC=CC=C3 | |
| TCMBANKIN059827 | phenol,2,6-bis(1,1-dimethylethyl)-4-methyl | C15H24O | 220.35 g/mol | CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C | |
| TCMBANKIN059860 | m-xylene | C8H10 | 106.17 g/mol | CC1=CC(=CC=C1)C | |
| TCMBANKIN059901 | p-xylene | C8H10 | 106.17 | CC1=CC=C(C=C1)C | |
| TCMBANKIN059908 | xylene | C8H10 | 106.17 | CC1=CC=C(C=C1)C.CC1=CC(=CC=C1)C.CC1=CC=CC=C1C | |
| TCMBANKIN059964 | α-cadinol | C15H26O | 222.37g/mol | CC1=CC2C(CCC(C2CC1)(C)O)C(C)C | |
| TCMBANKIN060043 | 3-methyl-6,7,8-trihydropyrrolo[1,2-a]pyrimidin-2-one | C8H10N2O | 150.18 g/mol | CC1=CN2CCCC2=NC1=O | |
| TCMBANKIN060088 | licoricesaponine k2 | C42H62O16 | 822.9 g/mol | CC12CCC(CC1=C3C=CC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)C(=O)O)O)O)O)C)(C)C(=O)O | |
| TCMBANKIN060090 | licorice-saponin G2 | C42H62O17 | 838.9 g/mol | CC12CCC(CC1C3=CC(=O)C4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)C(=O)O)O)O)O)C)(C)C(=O)O | |
| TCMBANKIN060092 | licorice-saponin J2 | C42H64O16 | 824.9 g/mol | CC12CCC(CC1C3=CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)C(=O)O)O)O)O)C)(C)C(=O)O | |
| TCMBANKIN060176 | naringin;Naringenin- 7- O- β- D- neohesperidoside | C27H32O14 | 580.53 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O | |
| TCMBANKIN060177 | licorice-saponin F3 | C48H72O19 | 953.1 g/mol | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(C(OC3OC4CCC5(C(C4(C)C)CCC6(C5CC=C7C6(CCC8(C7CC9(CC8OC9=O)C)C)C)C)C)C(=O)O)O)O)C(=O)O)O)O)O)O)O | |
| TCMBANKIN060264 | rutin | C27H30O16 | 610.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O | |
| TCMBANKIN060433 | gmelofuran;gmeloiuran | C15H18O3 | 246.3 g/mol | CC1CC2C(CC(=O)C3=COC(=C23)C1=O)C(C)C | |
| TCMBANKIN060592 | (+)-Neomatatabiol | C10H18O2 | 170.25 g/mol | CC1CCC2C1C(OCC2C)O | |
| TCMBANKIN060599 | Methylcyclopentane | C30H54S2;C6H12 | 478.88;84.16 | CC1CCCC1 | |
| TCMBANKIN060607 | methylcyclohexane | C7H14 | 98.19 g/mol | CC1CCCCC1 | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060705 | methyl linoleate | C19H34O2 | 294.47 | CCC=CCC=CCC=CCCCCCCCC(=O)OC | |
| TCMBANKIN060735 | EB | C8H10 | 106.16 g/mol | CCC1=CC=CC=C1 | |
| TCMBANKIN060772 | 2-methyl pentane | C6H14 | 86.18 g/mol | CCCC(C)C | |
| TCMBANKIN060773 | 3-methylhexane | C7H16 | 100.2 | CCCC(C)CC | |
| TCMBANKIN060807 | 3-methylheptane | C8H18 | 114.23 | CCCCC(C)CC | |
| TCMBANKIN060816 | Octadiene | C8H14 | 110.2 g/mol | CCCCC=CC=C | |
| TCMBANKIN060837 | HEX | C6H14 | 86.18 g/mol | CCCCCC | |
| TCMBANKIN060850 | 2-methyl-Heptane | C8H18 | 114.23 g/mol | CCCCCC(C)C | |
| TCMBANKIN060891 | 2-Amyl furan | C9H14O | 138.21 g/mol | CCCCCC1=CC=CO1 | |
| TCMBANKIN060896 | Heptan | C7H16 | 100.2 | CCCCCCC | |
| TCMBANKIN060918 | WLN: VH6 | C7H14O | 114.19 | CCCCCCC=O | |
| TCMBANKIN060922 | Octane | C8H18 | 114.23 g/mol | CCCCCCCC | |
| TCMBANKIN061105 | Eicosanoic acid | C20H40O2 | 312.53 g/mol | CCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061122 | tricosane | C23H48 | 324.63 g/mol | CCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061202 | Butanol | C4H10O | 74.12 g/mol | CCCCO | |
| TCMBANKIN061205 | WLN: 4OVR | C11H14O2 | 178.23 g/mol | CCCCOC(=O)C1=CC=CC=C1 | |
| TCMBANKIN061207 | Di-n-butyl phthalate | C16H22O4 | 278.34 g/mol | CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC | |
| TCMBANKIN061426 | dimethyl sebacate | Sebacic acid, dimethyl ester; NSC9415; ST50307409; Tox21_200178; dimethyl decane-1,10-dioate; MolPort-001-785-599; AE currencyO notEa paragraph signthorn(1/4)xo yen; DTXSID1026740; KSC174O5R; BB_SC-00429; EC 203-431-4; CJ-28662; DSSTox_RID_78206; CC-26989; DIMETHYL SEBACATE; AC1L1PN9; CTK0H4758; SBB060773; STK018255; BB_SC-0429; Dimethyl octane-1,8-dicarboxylate; TR-001350; AI3-00662; ANW-15441; CAS-106-79-6; RTR-001350; NCGC00248552-01; 106-79-6; MFCD00008472; RL00291; SCHEMBL35275; G87745M355; EINECS 203-431-4; CHEMBL3186083; CJ-06668; Dimethyl decanedioate; Dimethyl sebacate, >=95%; I811; AUO notEa paragraph signthorn(1/4)xo yen; AC1Q5ZZ4; NCGC00257732-01; S0027; NSC-9415; Sebacic acid, dimethyl ester (8CI); Decanedioic acid, dimethyl ester; Decanedioic Acid Dimethyl Ester; DSSTox_CID_6740; TRA0077474; AN-22447; BBL009825; J-001650; KS-00000YSZ; ZINC1699974; C-34415; DSSTox_GSID_26740; Decanedioic acid, 1,10-dimethyl ester; ACMC-2098mb; 1,10-dimethyl decanedioate; UNII-G87745M355; Methyl sebacate; ACN-S002413; 1,8-Octanedicarboxylic Acid Dimethyl Ester; LS-178727; ALOUNLDAKADEEB-UHFFFAOYSA-N; AKOS005378294; Dimethyl sebacate, 99%; FT-0653197; 1,8-Octanedicarboxylic acid-bis-methyl ester; I14-5854; NSC 9415; Dimethyl sebacate, analytical standard; MCULE-8633671524; Sebacic acid dimethyl ester; EINECS 203-431-4; Dimethyl decanedioate; Dimethyl octane-1,8-dicarboxylate; decanedioic acid dimethyl ester; AI3-00662; Sebacic acid, dimethyl ester (8CI); Decanedioic acid, dimethyl ester; Dimethyl sebacate; 223115_ALDRICH; ZINC01699974; ST5307409; NSC 9415; 106-79-6; Sebacic acid dimethyl ester | C12H22O4 | 230.3 g/mol | COC(=O)CCCCCCCCC(=O)OC |
| TCMBANKIN061496 | calycosin | HSDB 8109; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)chromen-4-one; CHEBI:17793; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one; 09N3E8P7TA; calycosin (OLD); 20575-57-9; HY-N0519; ZINC6018563; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-1-benzopyran-4-one; 3'-hydroxy-formononetin; calycosin ; LMPK12050056; MEGxp0_001325; BRD-K05039497-001-01-6; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; 3',7-dihydroxy-4'-methoxy-isoflavone; AKOS015896719; UNII-09N3E8P7TA; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-; 3', 7-dihydroxy-4'-methoxyisoflavone; 575C579; C01562; HMS2268B05; C-17889; MolPort-001-741-659; Calycosin; X1103; SCHEMBL73013; Q-100254; AC1NQX1G; 7-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)chromen-4-one; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4-chromenone; 7-hydroxy-3-(3-hydroxy-4-methoxy-phenyl)chromone; CHEMBL241608; CS-3715; ZZAJQOPSWWVMBI-UHFFFAOYSA-N; BG01576591; MLS000876988; DTXSID70174580; 3',7-dihydroxy-4'-methoxyisoflavone; ACon1_000650; I07-0176; NP-004576; NCGC00169494-01; 3-(4-methoxy-3-oxidanyl-phenyl)-7-oxidanyl-chromen-4-one; MCULE-7559555984; 7,3'-dihydroxy-4'-methoxyisoflavone; A814711; N1412; 3'-hydroxyformononetin; FT-0630465; MFCD00210598; SMR000440659; AN-8397; AC-8043; 3',7-dihydroxy-4'-methoxy-isoflavone | C16H12O5 | 284.26 g/mol | COC1=C(C=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O)O |
| TCMBANKIN061499 | odoratin | ZINC14759160; NCGC00385697-01!7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-6-methoxychromen-4-one; BDBM50441625; 53948-00-8; 3',7-dihydroxy-4',6-dimethoxyisoflavone; CHEMBL469824; MCULE-3526258136; LMPK12050113; Odoratin; SCHEMBL1248967 | C19H20O6 | 344.36 | COC1=C(C=C(C=C1)C2=COC3=CC(=C(C=C3C2=O)OC)O)O |
| TCMBANKIN061528 | scopoletin | NINDS_000720; 7-hydroxy-6-methoxy-coumarin; NCGC00016349-05; 6-methoxy-7-hydroxycoumarin; 6-methoxy-7-oxidanyl-chromen-2-one; CHEBI:17488; SPBio_002884; HMS1571A05; RODXRVNMMDRFIK-UHFFFAOYSA-N; NCGC00016349-08; TR-029034; 5-18-03-00203 (Beilstein Handbook Reference); Acid, Gelseminic; 6-Methylesculetin; UNII-KLF1HS0SXJ; 7-hydroxy 6-methoxy coumarine; Scopoletin, >=99%; AB00443525; beta -methylesculetin; CS-5791; BRN 0156296; NCGC00094973-02; SR-01000841273-4; HMS2268G04; SCHEMBL147702; scopoletin ; Prestwick3_000962; CHEMBL71851; Escopoletin; Spectrum2_001207; HMS2098A05; NCGC00016349-07; NCGC00094973-03; Murrayetin; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; Bio-0208; NCGC00016349-02; Prestwick2_000962; ZB002243; BG01509594; NCGC00016349-03; BPBio1_001061; Scopoletin, analytical standard; AX8035441; 0B4B9FAA-686D-4977-AA08-65F8E4F1977C; BRD-K96163925-001-06-5; ZX-AN021883; FCH1115349; AC1NQX27; 7-hydroxy-6-methoxy-chromen-2-one; KBio3_002444; DTXSID0075368; 7-Hydroxy-5-methoxycoumarin; SC-90283; ST24045669; b-Methylaesculetin; KBioGR_001348; 7-Hydroxy-6-methoxy-2H-chromen-2-one #; Gelseminic acid; ZX-AFC000681; S0367; MLS002154074; 4CN-0905; 6-O-Methylesculetin; HMS502D22; KLF1HS0SXJ; MCULE-6077230919; MLS002472878; IDI1_000720; SPECTRUM1502242; Aesculetin 6-methyl ether; C-30831; MFCD00006872; Scopoletol; Buxuletin; AB0019688; CC-34387; Chrysotropic Acid; RTR-029034; ACon1_000143; CCRIS 3592; 6-Methoxyumbelliferone; LS-55217; NSC-405647; NSC 405647; 6-Methoxy-7-hydroxycoumarin; Esculetin-6-methyl ether; BDBM50156693; ZX-AT021192; AK111291; Scopoletin, United States Pharmacopeia (USP) Reference Standard; 7-Hydroxy-6-methoxy-2H-chromen-2-one; I14-14171; Prestwick1_000962; PubChem15777; MolPort-000-707-493; DivK1c_000720; A844290; AN-42608; NCGC00016349-04; ST056287; ZINC57733; BSPBio_002944; Chrysatropic acid; NCI60_003834; CAS-92-61-5; Acid, Chrysotropic; NSC405647; SR-01000841273; Prestwick0_000962; BSPBio_000963; KBio1_000720; FT-0631451; beta-Methylesculetin; Spectrum4_001054; SR-01000841273-3; AJ-09778; 7-Hydroxy-6-methoxycoumarin; W-3522; MEGxp0_001192; HY-N0342; NCGC00016349-06; Scopoletine; 7-hydroxy-6-methoxy-1-benzopyran-2-one; 006S872; OR22352; S-2000; NCGC00094973-01; EINECS 202-171-9; TNP00096; KS-00000YGS; Spectrum5_000654; Spectrum3_001532; TD8126; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); SPBio_000994; AKOS000277133; COUMARIN, 7-HYDROXY-6-METHOXY-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; SMR000112541; BIDD:PXR0125; CCG-39140; Esculetin 6-methyl ether; D05QOR; 92-61-5; ALBB-023369; 7-hydroxy-6-methoxychromen-2-one; C01752; BIS1402; HMS1921N16; KB-249948; .beta.-Methylesculetin; NCGC00016349-01; Baogongteng B; 7-hydroxy-6-methoxy-chromen-2-one; KBio3_002444; NINDS_000720; 7-Hydroxy-5-methoxycoumarin; 7-hydroxy-6-methoxy-coumarin; Scopoletine; S2500_SIGMA; 7-hydroxy-6-methoxy-2H-chromen-2-one; CHEBI:17488; KBioGR_001348; SPBio_002884; Prestwick1_000962; NCGC00094973-01; 5-18-03-00203 (Beilstein Handbook Reference); EINECS 202-171-9; scopoletol; TNP00096; AIDS-014975; Gelseminic acid; DivK1c_000720; 6-O-Methylesculetin; Spectrum5_000654; Spectrum3_001532; 6-Methylesculetin; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); MEGxp0_001192; SPBio_000994; Scopoletin; 84792_FLUKA; IDI1_000720; COUMARIN, 7-HYDROXY-6-METHOXY-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; ST056287; NCGC00094973-02; BRN 0156296; SPECTRUM1502242; Esculetin 6-methyl ether; BSPBio_002944; Chrysatropic acid; NCI60_003834; CAS-92-61-5; Prestwick3_000962; 7-hydroxy-6-methoxy-2-chromenone; Escopoletin; Spectrum2_001207; NCGC00094973-03; Murrayetin; 92-61-5; NSC405647; BSPBio_000963; NCGC00016349-02; KBio1_000720; 7-hydroxy-6-methoxychromen-2-one; Prestwick0_000962; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; C01752; ZINC00057733; AIDS014975; Prestwick2_000962; Spectrum4_001054; beta-Methylesculetin; ACon1_000143; BPBio1_001061; CCRIS 3592; 6-Methoxyumbelliferone; 7-Hydroxy-6-methoxycoumarin; .beta.-Methylesculetin; NCGC00016349-01; NSC 405647; 6-Methoxy-7-hydroxycoumarin; Esculetin-6-methyl ether; 6-methoxy-7-hydroxycoumarin; 7- hydroxy- 6-methoxy- coumarin; 6-methoxy-7-hydroxy coumarin; Scopoletol | C10H8O4 | 192.17 g/mol | COC1=C(C=C2C(=C1)C=CC(=O)O2)O |
| TCMBANKIN061590 | isorhamnetin | 3'-O-Methylquercetin; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxy-phenyl)chromone; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxy-phenyl)chromen-4-one; Isorhamnetin; BRN 0044723; Flavone, 3,3',5,7-tetrahydroxy-4'-methoxy-; C10084; Quercetin 3'-methyl ether; 3'-Methoxyquercetin; CCRIS 3791; 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)- (9CI); C.I. 75680; 4'-Methoxy-3,3',5,7-tetrahydroxy-flavone; ST5309356; Quercetin, 4'-methyl ether; Flavone, 3'-methoxy-3,4',5,7-tetrahydroxy-; AIDS-003060; 480-19-3; ACon1_000275; AIDS003060; 4'-O-Methylquercetin; 3-Methylquercetin; Oprea1_145406; ZINC00517261; 4'-Methoxyquercetin; NCGC00163572-01; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one; BRN 0324993; 4H-1-Benzopyran-4-one, 2-(3-methoxy-4-hydroxyphenyl)-3,5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)- (9CI); EINECS 210-050-7; 3'-Methoxy-3,4',5,7-tetrahydroxyflavone; MEGxp0_001863; NCGC00163572-02; EINECS 207-545-5; Isorhamnetol; 3,5,7-Trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone; 17794_FLUKA; FLAVONE, 4'-METHOXY-3,3',5,7-TETRAHYDROXY-; 4'-Methylquercetin; 5-18-05-00496 (Beilstein Handbook Reference); 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-chromenone; 3-Methylquercetine; FLAVONE, 3,4',5,7-TETRAHYDROXY-3'-METHOXY-; 3-methylquercetin; quercetin-3'-methyl ether | C16H12O7 | 316.26 g/mol | COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN061591 | Quercetin der.; | Flavone, 4',5,7-trihydroxy-3,3'-dimethoxy- (8CI); Quercetin-3,3'-dimethyl ether; AIDS-071757; 4382-17-6; Quercetin-3,3-dimethyl ether; 5,7-dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3-methoxy-chromen-4-one; Quercetin-3,3'-dimethylether; Quercetin 3,3'-dimethyl ether; NSC 254669; 3,3'-Di-O-methylquercetin; 5,7-dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3-methoxy-chromone; 3,3'-Dimethylquercetin; 3,3'-Dimethoxyquercetin; NSC254669; 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy-4-chromenone; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy-; Flavone, 4',5,7-trihydroxy-3,3'-dimethoxy-; AIDS071757; 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxychromen-4-one; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy- (9CI); 4H-1-Benzoyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy-; 4',5,7-trihydroxy-3,3'-dimethoxyflavone; Quercetin-3,3'-dimethyl ether; NSC-254669; 4382-17-6; LMPK12112752; CHEMBL511363; 5,7,4'-Trihydroxy-3,3'-dimethoxyflavone; Flavone,5,7-trihydroxy-3,3'-dimethoxy-; Quercetin-3,3-dimethyl ether; 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxychromen; Quercetin-3,3'-dimethylether; Quercetin 3,3'-dimethyl ether; FMEHGPQTMOPUGM-UHFFFAOYSA-N; NSC 254669; 3,3'-Di-O-methylquercetin; 4H-1-Benzopyran-4-one,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy-; UNII-J03N0KJ42I; SCHEMBL1252850; 3,3'-Dimethylquercetin; 3,3'-Dimethoxyquercetin; NSC254669; DTXSID60195941; 3,3'-Dimethylquercetol; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy-; AC1NSUVV; Flavone, 4',5,7-trihydroxy-3,3'-dimethoxy-; 3,3'-O-DIMETHYLQUERCETIN; J03N0KJ42I; 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxychromen-4-one; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy- (9CI); 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy-4H-chromen-4-one #; 4H-1-Benzoyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxy-;quercetin 3,3′-dimethyl ether;3,3'-dimethylquercetin;quercetin- 3,3′- dimethylether | C17H14O7 | 330.29 g/mol | COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC)O |
| TCMBANKIN061665 | hispidulin | 447H887; 5,7,4'-trihydroxy-6-methoxyflavone; Dinatin; 6-methoxyapigenin; LS-173226; CTK8G0189; NSC 122415; BDBM50049395; UNII-N7F61604C2; B6959; 4H-1-Benzopyran-4-one,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-; hispidulin ; ACon1_000933; MLS000728540; NP-001963; ZINC5732241; 4',7-Trihydroxy-6-methoxyflavone; MCULE-3882973229; SCHEMBL514926; HMS3344G13; C10058; 4?,5,7-Trihydroxy-6-methoxyflavone; PubChem SID: 26725244; W1618; MolPort-001-740-838; NSC122415; KS-00001FKN; MEGxp0_000683; Hispidulin; Oprea1_873387; cid_5281628; methoxyapigenin; BRD-K72066874-001-01-0; Flavone,5,7-trihydroxy-6-methoxy-; TCMDC-123942; N7F61604C2; FT-0697687; 1447-88-7; Scutellarein 6-methyl ether; CCRIS 8484; HMS2223A03; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one; 6-methylscutellarein; HY-N1950; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one #; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-chromen-4-one; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxychromen-4-one; Flavone, 4',5,7-trihydroxy-6-methoxy-; SMR000445653; AN-49210; 4H-1-Benzopyran-4-one, 5, 7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-; 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-6-methoxy-chromen-4-one; hispidulin(dinatin); AKOS004110694; NCGC00167728-02; 6-methoxy apigenin; 5,7,4''-Trihydroxy-6-methoxyflavone; HUL; 4CN-1206; DTXSID30162786; NCI60_000530; CS-6502; IHFBPDAQLQOCBX-UHFFFAOYSA-N; ST024778; 4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-METHOXY-; CHEBI:75902; AC1NQYRM; BG01592767; C-56393; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; NCGC00167728-01; CHEMBL293776; NSC-122415; NCGC00169216-01; Q-100165; 6-O-Methylapigenin; 4H-1-Benzopyran-4-one,5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-; LMPK12111159; 4',5,7-Trihydroxy-6-methoxyflavone; Dinatin; NCI60_000530; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one; AIDS126680; NSC122415; MEGxp0_000683; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-chromenone; Hispidulin; ST024778; Oprea1_873387; 4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-METHOXY-; NSC 122415; ZINC00113457; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-chromen-4-one; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxychromen-4-one; Flavone, 4',5,7-trihydroxy-6-methoxy-; SMR000445653; AIDS-126680; ACon1_000933; 4H-1-Benzopyran-4-one, 5, 7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-; MLS000728540; 6-O-Methylapigenin; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-chromone; 1447-88-7; C10058; Scutellarein 6-methyl ether; 4',5,7-Trihydroxy-6-methoxyflavone; 6-methoxyapigenin | C16H12O6 | 300.26 g/mol | COC1=C(C2=C(C=C1O)OC(=CC2=O)C3=CC=C(C=C3)O)O |
| TCMBANKIN061671 | dl-tetrahydropalmatine | dl-tetrahydropalmatine;AIDS002241; 84-38-8; 13a-alpha-Berbine, 2,3,9,10-tetramethoxy-; CHEBI:16563; 6H-Dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, (S)-; (S)-5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo(a,g)quinolizine; AIDS-002241; C02890; Hyndarine; (-)-Corydalis; 4880-82-4 (HCL); NSC36363 (HCL); InChI=1/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s; 5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo(a,g)quinolizine; 5,8,13,13a(S)-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo[a,g]quinolizine; 2-(2,3-Dimethoxy-benzyl)-1-ethyl-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline; BB_NC-1018; Gindarine; Tetrahydropalmatine (6CI); Berbine, 2,3,9,10-tetramethoxy- (8CI); Tetrahydropalmatine; l-Tetrahydropalmatine; (S)-Tetrahydropalmatine; Caseanine; 6H-Dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-; Rotundine; (13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline; 483-14-7; (13aS)-2,3,9,10-tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline; 6H-dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, (13aS)-; (-)-Tetrahydropalmatine;2,3,9,10-Tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[3,2-a]isoquinoline hydrochloride; 2,3,9,10-Tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline hydrochloride; AKOS024399264; MolPort-002-321-247; Berbine,3,9,10-tetramethoxy-, hydrochloride; NSC-132057; NSC-209411; 2,3,9,10-Tetramethoxyberbine hydrochloride; 6024-85-7; CHEMBL1412574; NSC132058; Palmatine, hydrochloride, (.+-.)-; 6H-Dibenzo[a, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride, (R)-; Tetrahydropalmatine hydrochloride; 024T857; C-55689; MCULE-7006385138; Palmatine, hydrochloride, (+)-; A832652; 6H-Dibenzo[a, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride; MLS000029596; Ambotz6024-85-7; 2506-20-9; FT-0698667; 6H-Dibenzo[a, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride, (.+-.)-; WLN: T D6 B666 KN&TT&J GO1 HO1 PO1 QO1 &GH; AC1O7ERI; NSC132057; NSC-132058; MLS002535962; AK310574; 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline hydrochloride; AC-8031; 13a.beta.-Berbine,3,9,10-tetramethoxy-, hydrochloride; Berbine,3,9,10-tetramethoxy-, hydrochloride, (+)-; NSC209411; Berbine,3,9,10-tetramethoxy-, hydrochloride, (.+-.)-; 3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5H-6000000-azatetraphene hydrochloride; SCHEMBL3502167; AC1Q3C4E; D-Tetrahydropalmatine hydrochloride; Tetrahydropalmatine, HCl; SMR000008833;(13aR)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline;Hyndarin;tetrahydropalmatine;L-tetrahydropalmatine;STOCK1N-14407 | C21H25NO4 | 355.4 g/mol | COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)OC)C=C1)OC |
| TCMBANKIN061723 | Jaranol | 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-; Flavone, 4',5-dihydroxy-3,7-dimethoxy-; 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-4-chromenone; AIDS039056; ACon1_000321; MEGxp0_000177; 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-chromen-4-one; 3301-49-3; Kumatakenin; 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxychromen-4-one; 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-chromone; AIDS-039056; Flavone, 4',5-dihydroxy-3,7-dimethoxy-; BJBUTJQYZDYRMJ-UHFFFAOYSA-N; UNII-5FAQ11412T; Jaranol; 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-chromen-4-one; SCHEMBL3351483; ZINC5732364; NCGC00169188-01; ACon1_000321; MolPort-001-740-355; 4CN-1330; DTXSID90186645; AC1NSXDF; CHEMBL349724; AKOS032948397; MEGxp0_000177; Kumatakenin; 3301-49-3; 5,4'-dihydroxy-3,7-dimethoxyflavone; Kumatakillin; Kaempferol 3,7-dimethyl ether; 5FAQ11412T; 5-Hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-4H-chromen-4-one #; 4H-1-Benzopyran-4-one,5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-; 4',5-Dihydroxy-3,7-dimethoxyflavone; LMPK12112690; 3,7-Di-O-methyl kaempferol; 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxychromen-4-one; kumatakenin | C17H14O6 | 314.29 | COC1=CC(=C2C(=C1)OC(=C(C2=O)OC)C3=CC=C(C=C3)O)O |
| TCMBANKIN061731 | prunetin | KBio2_006643; CHEBI:8600; Isoflavone, 4',5-dihydroxy-7-methoxy- (7CI,8CI); MFCD00016951; Padmakastein; CHEMBL491174; BIDD:ER0153; LS-39694; ST096009; KBio2_001507; D0A9RM; Spectrum4_001723; 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxychromen-4-one; CTK8G2643; SC-66909; Oprea1_083784; BRD-K57546357-001-01-6; KBio1_001533; GTPL6919; FT-0708556; KBioGR_002106; AKOS016010281; 4 inverted exclamation marka,5-Dihydroxy-7-methoxyisoflavone; UNII-1TG4H5H11J; 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-chromen-4-one; Prunetin (6CI); Prunusetin; SCHEMBL73420; 552P590; BSPBio_003044; Spectrum5_000486; ZINC18847044; AJ-70677; 5-18-04-00595 (Beilstein Handbook Reference); MolPort-003-939-175; C-57556; KBio3_002264; 5-Hydroxy-3-(4-hydroxyphenyl)-7-methoxy-4H-1-benzopyran-4-one; Y0172; 4',5-dihydroxy-7-methoxygenistein; AK114738; 5,4'-dihydroxy-7-methoxy-isoflavone; 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-chromone; 4H-1-Benzopyran-4-one, 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-; 552-59-0; Spectrum_001027; 7-O-Methyl genistein; AN-45849; 82415_FLUKA; LMPK12050353; KBioSS_001507; EINECS 209-018-5; NCGC00178331-01; 4CN-1042; ST50320097; SMP1_000150; BDBM50359990; AC1NQZ4E; BRN 0292155; 5,4'-dihydroxy-7-methoxyisoflavone; Prunetin, >=98.0% (TLC); ZINC00057630; KQMVAGISDHMXJJ-UHFFFAOYSA-N; C10521; 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one; Prunetin; Spectrum3_001402; SpecPlus_000493; 4',5-dihydroxy-7-methoxyisoflavone; DivK1c_006589; KBio2_004075; prunetin ; 5-Hydroxy-3-(4-hydroxyphenyl)-7-methoxy-4-benzopyrone; 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-4-chromenone; 5-Hydroxy-3-(4-hydroxyphenyl)-7-methoxy-4H-1-benzopyran-4-one, 9CI; ST5320097; 1TG4H5H11J; CCRIS 8951; AX8092606; 7-O-methyl-genistein; DTXSID3022530; Padmakastein | C16H12O5 | 284.26 g/mol | COC1=CC(=C2C(=C1)OC=C(C2=O)C3=CC=C(C=C3)O)O |
| TCMBANKIN061840 | 7,4'-dimethoxyisoflavone | Daidzein dimethyl ether; 4H-1-Benzopyran-4-one, 7-methoxy-3-(4-methoxyphenyl)-; SPBio_000109; ZINC00057588; Spectrum4_001605; 7-Methoxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one; KBio2_003745; Spectrum2_000185; 7,4'-Dimethoxyisoflavone; KBio3_001297; 7-methoxy-3-(4-methoxyphenyl)chromone; KBio2_001177; ST5331724; Spectrum5_000329; Spectrum_000697; 7-methoxy-3-(4-methoxyphenyl)chromen-4-one; Spectrum3_000209; DivK1c_006209; Oprea1_523121; 7-Methoxy-3-(4-methoxyphenyl)-4H-chromen-4-one; 4',7-Dimethoxyisoflavone; KBio2_006313; 1157-39-7; KBioSS_001177; KBio1_001153; 7-methoxy-3-(4-methoxyphenyl)-4-chromenone; 38763_FLUKA; KBioGR_001949; 7-Methoxy-3-(p-methoxyphenyl)-4H-chromen-4-one; SpecPlus_000113 | C17H14O4 | 282.29 g/mol | COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)OC |
| TCMBANKIN061841 | Calycosin-7-0-β-D-glucopyranoside | 4H-1-Benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-3-(4-methoxyphenyl)-; MEGxp0_000395; 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; LMPK12050014; 486-62-4; 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Formononetin glucoside; STOCK1N-14986; 75375_FLUKA; 3-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside; ACon1_000463; ZINC01081322; 3-(4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; CHEBI:7775; 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Ononin; C10509; Formononetin 7-O-glucoside; Formononetin-7-O-beta-D-glucopyranoside; Formononetin-7-glucoside; ononin | C22H22O9 | 430.4 | COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)OC4C(C(C(C(O4)CO)O)O)O |
| TCMBANKIN061878 | HMO | 3-(4-hydroxyphenyl)-7-methoxy-chromen-4-one; Isoformononetin; 3-(4-hydroxyphenyl)-7-methoxychromen-4-one; 4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-methoxy-; 7-methoxy-4'-hydroxyisoflavone; C12125; 4'-HYDROXY-7-METHOXYISOFLAVONE; 3-(4-hydroxyphenyl)-7-methoxy-4-chromenone; 3-(4-hydroxyphenyl)-7-methoxy-chromone;isoformononetin | C16H12O4 | 268.26 g/mol | COC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O |
| TCMBANKIN061887 | medicarpin-3-o-glucoside | (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; Medicarpin 3-O-glucoside; C16223; (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-yl]oxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzoxolo[3,2-c]chromen-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | C22H24O9 | 432.4 g/mol | COC1=CC2=C(C=C1)C3COC4=C(C3O2)C=CC(=C4)OC5C(C(C(C(O5)CO)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab